Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,9.314608836124997e-43,24.19385593220339,2341.4710944509993,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",4.862225812457249e-40,0,0,69
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.3274091652531755e-17,6.982399714107031,271.3410630030774,"['NDUFB9', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'SLC25A4', 'SLC25A6']",3.464537921310788e-15,0,0,46
3,Nonalcoholic fatty liver disease WP4396,1.7093446492186073e-08,3.131765935214211,56.010289262162374,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'CASP7', 'CASP8', 'LEPR', 'MLX', 'UQCRFS1', 'CYC1', 'COX8A', 'XBP1', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",2.9742596896403766e-06,0,0,43
4,Mitochondrial CIV Assembly WP4922,2.8987328756774442e-08,7.903926913725779,137.183772743795,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",3.7828464027590648e-06,0,0,18
5,Oxidative phosphorylation WP623,8.520982853036603e-08,5.056840005909292,82.31599534540929,"['NDUFB9', 'ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFB10', 'NDUFA5', 'NDUFB5', 'NDUFA4', 'ATP6AP2', 'NDUFB2', 'ATP5MC3', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'ATP5F1B', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",8.895906098570214e-06,0,0,23
6,Allograft Rejection WP2328,2.316818168910027e-05,4.463303826518664,47.63563977069623,"['C1QA', 'ABCB1', 'TGFB1', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'HLA-E', 'C3', 'CASP7', 'CASP8', 'C6', 'IL5', 'COL5A1', 'HLA-DRA', 'VIM']",0.0020156318069517237,0,0,16
7,Computational Model of Aerobic Glycolysis WP4629,0.00021355114328310297,10.706410256410257,90.48666315713413,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.01592481382768282,0,0,7
8,Glycolysis and Gluconeogenesis WP534,0.00029784871567188853,4.324935732647815,35.113828263193106,"['LDHA', 'TPI1', 'PKM', 'GOT1', 'PGAM1', 'PGK1', 'ALDOC', 'ENO2', 'ALDOA', 'PFKM', 'GAPDH', 'GCK']",0.017715884742457843,0,0,12
9,Mitochondrial complex I assembly model OXPHOS system WP4324,0.0003054462886630663,3.1602155576382382,25.577952352241333,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC1', 'TMEM186', 'NDUFS6', 'NDUFS5']",0.017715884742457843,0,0,17
10,Cholesterol Biosynthesis Pathway WP197,0.0003900848534619122,6.99376969874661,54.89512134084714,"['IDI1', 'SQLE', 'HMGCS1', 'CYP51A1', 'MSMO1', 'HMGCR', 'DHCR7', 'FDFT1']",0.018511299409738016,0,0,8
11,Mitochondrial complex III assembly WP4921,0.0003900848534619122,6.99376969874661,54.89512134084714,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.018511299409738016,0,0,8
12,"GPCRs, Class A Rhodopsin-like WP455",0.0007175808911724871,2.3395166654349273,16.937223049776875,"['NPFFR2', 'OXTR', 'GPR34', 'GPR68', 'P2RY14', 'GPR22', 'CHRM5', 'HTR2B', 'OPRK1', 'GPR83', 'NMBR', 'GPR3', 'SSTR1', 'ADRA2C', 'MCHR1', 'HCRTR2', 'MC4R', 'ADORA2A', 'LPAR6', 'GPER1', 'ACKR4', 'RGL4', 'NTSR1', 'OR3A2']",0.031214768766003192,0,0,24
13,Peptide GPCRs WP24,0.0008965165468405291,3.962487153134635,27.804747817560678,"['MC4R', 'OXTR', 'C5AR1', 'GNRHR', 'TAC4', 'OPRK1', 'SSTR1', 'NMBR', 'NTSR1', 'TSHR', 'HCRTR2']",0.033427259817911156,0,0,11
14,TYROBP causal network in microglia WP3945,0.0008965165468405291,3.962487153134635,27.804747817560678,"['APBB1IP', 'C3', 'RBM47', 'CD4', 'IGSF6', 'DPYD', 'IL18', 'LHFPL2', 'SAMSN1', 'TMEM106A', 'ZFP36L2']",0.033427259817911156,0,0,11
15,Selenium Micronutrient Network WP15,0.000970706294630373,2.8851107676455436,20.015417326516065,"['SERPINA3', 'GPX2', 'GPX4', 'DIO1', 'APOA1', 'KMO', 'SELENOK', 'SELENOH', 'SELENOM', 'PRDX5', 'RFK', 'SELENOW', 'PNPO', 'SEPHS2', 'LDLR', 'MSRB1']",0.03378057905313698,0,0,16
16,Proximal tubule transport WP4917,0.0010816388389955336,3.3185442386831276,22.663260977038618,"['SLC47A2', 'ATP6V1G1', 'SLC22A6', 'ABCC2', 'ABCB1', 'SLC3A1', 'ATP1B1', 'SLC7A9', 'ATP6V0A4', 'ATP6V1E1', 'ATP6V0C', 'ATP6V1D', 'ATP6V1F']",0.035288467122229286,0,0,13
17,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.002792495879709783,inf,inf,"['TGFB1', 'IL5', 'VIP']",0.08574604995344158,0,0,3
18,Cytokines and Inflammatory Response WP530,0.004242408346309744,7.639600409836065,41.7322658080918,"['CD4', 'TGFB1', 'IL5', 'IL7', 'HLA-DRA']",0.12302984204298259,0,0,5
19,Drug Induction of Bile Acid Pathway WP2289,0.004644997612508917,12.219150025601639,65.64083918882633,"['ABCB1', 'ABCC2', 'SLC10A1', 'SLC51A']",0.12761519756471867,0,0,4
20,Cori Cycle WP1946,0.005473805682220225,5.239950208684191,27.288514014424294,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.14286632830594787,0,0,6
21,Nanomaterial induced apoptosis WP2507,0.005803612067646239,4.280410256410256,22.041008602732507,"['CASP7', 'ENDOG', 'CASP8', 'HTRA2', 'BAX', 'CYCS', 'FADD']",0.1442612142529208,0,0,7
22,Complement Activation WP545,0.007506314083934558,6.111168032786885,29.895899618329803,"['C3', 'C1QA', 'C6', 'MASP2', 'CFP']",0.1781043614460836,0,0,5
23,Complement system WP2806,0.00896139660459961,2.53275418845847,11.94150338667222,"['C3', 'FKBP2', 'C6', 'RPS19', 'C5AR1', 'APOA1', 'C4BPA', 'MASP2', 'CD59', 'CALR', 'LRP2', 'CFP']",0.2033847403304781,0,0,12
24,Sleep regulation WP3591,0.010472416930230417,3.261570035915854,14.86953183590774,"['OXTR', 'AHCY', 'STAR', 'ADORA2A', 'IL18', 'CRH', 'FOS', 'HCRTR2']",0.22777506823251156,0,0,8
25,Spinal Cord Injury WP2431,0.01213444275120245,1.9401960784313725,8.55957732225794,"['EGR1', 'TGFB1', 'CDKN1B', 'IL1R1', 'GADD45A', 'OMG', 'FOS', 'PDYN', 'TNFSF13B', 'LGALS3', 'NR4A1', 'ZFP36', 'CCND1', 'APEX1', 'SLIT3', 'LTB', 'SLIT2', 'VIM', 'ROS1']",0.2355030816090615,0,0,19
26,Development and heterogeneity of the ILC family WP3893,0.012181193876330768,5.092213114754099,22.445772695123907,"['IL5', 'IL7', 'IL18', 'AHR', 'TOX']",0.2355030816090615,0,0,5
27,Glycolysis in senescence WP5049,0.012181193876330768,5.092213114754099,22.445772695123907,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'GAPDH']",0.2355030816090615,0,0,5
28,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.017131314346581848,6.108550947260625,24.842543571423136,"['CCND1', 'EGF', 'FN1', 'VIM']",0.31937664603270444,0,0,4
29,Thyroxine (Thyroid Hormone) Production WP1981,0.01983904382168616,inf,inf,"['TG', 'TSHR']",0.3571027887903509,0,0,2
30,Metapathway biotransformation Phase I and II WP702,0.02058738209454551,1.7281653746770025,6.710599063995504,"['CHST8', 'CHST9', 'GPX2', 'GPX4', 'GSTP1', 'CYP3A43', 'CYP51A1', 'KCNAB1', 'GLYAT', 'CYP2C18', 'CYP3A5', 'FMO5', 'NAA80', 'CYP3A7', 'CYP39A1', 'CYP26A1', 'NDST4', 'GAL3ST2', 'NAT8L', 'SULT4A1', 'CHST2', 'CHST3']",0.3582204484450919,0,0,22
31,Complement and Coagulation Cascades WP558,0.022686533292435404,2.7172909184197023,10.287619336060887,"['C3', 'C1QA', 'CPB2', 'C6', 'SERPIND1', 'C5AR1', 'MASP2', 'F5']",0.38201194769842844,0,0,8
32,Oxidation by Cytochrome P450 WP43,0.02836826153968813,2.5740595717101886,9.17004683763634,"['CYP39A1', 'CYB5R1', 'CYP26A1', 'CYP3A43', 'CYP51A1', 'CYP3A5', 'CYP2C18', 'CYP3A7']",0.4627572663661626,0,0,8
33,Vitamin D Receptor Pathway WP2877,0.03206347222824648,1.7107843137254901,5.885162764349557,"['ABCB1', 'TGFB1', 'CDKN1B', 'IGFBP5', 'GADD45A', 'SEMA3B', 'G0S2', 'GXYLT2', 'CYP3A5', 'CEACAM1', 'DUSP10', 'CCND1', 'ADGRE5', 'CLMN', 'PNOC', 'TIMP2', 'TIMP3', 'LGALS9', 'ZNF257']",0.5071858334286261,0,0,19
34,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.03496030372201548,2.4451513596716263,8.19991788012246,"['NDUFA13', 'CASP7', 'HSP90AA1', 'CASP8', 'ACAP1', 'IL18', 'NLRC4', 'AAMP']",0.5367434865556494,0,0,8
35,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.04008151246886676,6.105936540429887,19.64182142990793,"['HEY1', 'VEGFB', 'VEGFC']",0.5640349480682855,0,0,3
36,miR-509-3p alteration of YAP1/ECM axis WP3967,0.040733246384555916,4.07168458781362,13.032284246051809,"['YAP1', 'COL5A1', 'PBX3', 'FN1']",0.5640349480682855,0,0,4
37,Nanoparticle triggered regulated necrosis WP2513,0.040733246384555916,4.07168458781362,13.032284246051809,"['CASP8', 'TRADD', 'FADD', 'FTL']",0.5640349480682855,0,0,4
38,Statin inhibition of cholesterol production WP430,0.041060015376618485,2.8200922603792926,9.003766351581596,"['SQLE', 'APOA1', 'HMGCR', 'ACSS1', 'LDLR', 'FDFT1']",0.5640349480682855,0,0,6
39,Base Excision Repair WP4752,0.05107116459840159,2.222491720695928,6.610879931859873,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'POLD1', 'APEX1', 'POLE2', 'POLE3']",0.6771816411027006,0,0,8
40,Striated Muscle Contraction Pathway WP383,0.051891313494459815,2.6184374313538843,7.74691912526396,"['ACTA2', 'MYOM1', 'ACTC1', 'TNNT2', 'VIM', 'ACTG1']",0.6771816411027006,0,0,6
41,Gastric acid production WP2596,0.0539322221097399,12.2076726342711,35.64673573656406,"['VIP', 'MUC6']",0.6866492668605909,0,0,2
42,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.05704872500420465,3.4897227708287617,9.994040992679775,"['GALNT3', 'CCND1', 'ROS1', 'FGFR3']",0.7090341536236864,0,0,4
43,Mevalonate pathway WP3963,0.0629187782720822,4.57906857727738,12.66529439910069,"['HMGCS1', 'HMGCR', 'ACAT2']",0.7141601395450758,0,0,3
44,Cardiac Progenitor Differentiation WP2406,0.06308514413745564,2.2511470985155198,6.22052717716259,"['MESP1', 'NOTCH1', 'TGFB1', 'ACTC1', 'TNNT2', 'THY1', 'DKK1']",0.7141601395450758,0,0,7
45,Pregnane X receptor pathway WP2876,0.06312655200154645,2.776406482861401,7.670138879304059,"['HSP90AA1', 'ABCB1', 'ABCC2', 'CYP3A5', 'CYP3A7']",0.7141601395450758,0,0,5
46,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.06312655200154645,2.776406482861401,7.670138879304059,"['BMP2', 'TGFB1', 'SUV39H1', 'FN1', 'IGFBP7']",0.7141601395450758,0,0,5
47,Heart Development WP1591,0.06430177501651066,2.4436699128651975,6.705840882247017,"['BMP2', 'NOTCH1', 'HEY1', 'VEGFB', 'VEGFC', 'FGF10']",0.7141601395450758,0,0,6
48,Pyrimidine metabolism WP4022,0.06848179430407132,1.604445908396044,4.301820066326007,"['NME2', 'NME1', 'NT5C', 'POLE4', 'POLD4', 'POLD1', 'POLE2', 'POLR1C', 'DPYD', 'POLE3', 'POLR2E', 'POLR1E', 'POLR2I', 'DCTPP1', 'POLR2K', 'POLR2L']",0.7447395130567757,0,0,16
49,Dopaminergic Neurogenesis WP2855,0.07632594999130404,3.0532514080901176,7.855229031133494,"['TGFB1', 'ASCL1', 'SLC18A2', 'GLI2']",0.7968429179092141,0,0,4
50,Galanin receptor pathway WP4970,0.07632594999130404,3.0532514080901176,7.855229031133494,"['YAP1', 'CDKN1B', 'PRKCD', 'FOS']",0.7968429179092141,0,0,4
51,Imatinib and Chronic Myeloid Leukemia WP3640,0.07944267215210646,2.544825819672131,6.4453302891961055,"['PDGFRB', 'SPRED2', 'ABCB1', 'CDKN1B', 'GADD45A']",0.7982778670733303,0,0,5
52,Differentiation Pathway WP2848,0.08866132152856855,2.036410256410256,4.934082647184862,"['NOTCH1', 'TGFB1', 'EGF', 'FST', 'FGF1', 'DKK1', 'FGF10']",0.7982778670733303,0,0,7
53,Apoptosis Modulation and Signaling WP1772,0.08980471463062917,1.5851775604734946,3.820464660360372,"['ENDOG', 'CRADD', 'IL1R1', 'TRADD', 'HTRA2', 'FOS', 'PTPN13', 'CASP7', 'CASP8', 'CYCS', 'BAX', 'PRKD1', 'FADD', 'BCL2L2']",0.7982778670733303,0,0,14
54,Bile acids synthesis and enterohepatic circulation  WP4389,0.09039128325152132,3.6629477993858752,8.804288584554373,"['SLC10A1', 'FGFR4', 'LDLR']",0.7982778670733303,0,0,3
55,HIF1A and PPARG regulation of glycolysis WP2456,0.09039128325152132,3.6629477993858752,8.804288584554373,"['LDHA', 'TPI1', 'GAPDH']",0.7982778670733303,0,0,3
56,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.09039128325152132,3.6629477993858752,8.804288584554373,"['ANXA2', 'APOA1', 'LDLR']",0.7982778670733303,0,0,3
57,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.09039128325152132,3.6629477993858752,8.804288584554373,"['CD4', 'HLA-DRA', 'CD247']",0.7982778670733303,0,0,3
58,Selective expression of chemokine receptors during T-cell polarization WP4494,0.09039128325152132,3.6629477993858752,8.804288584554373,"['CD4', 'TGFB1', 'IL5']",0.7982778670733303,0,0,3
59,Trans-sulfuration pathway WP2333,0.09039128325152132,3.6629477993858752,8.804288584554373,"['AHCY', 'GOT1', 'MAT2B']",0.7982778670733303,0,0,3
60,DNA Mismatch Repair WP531,0.09386549551672996,2.1558175294720656,5.100432352276845,"['POLE4', 'POLD4', 'POLD1', 'RPA3', 'POLE2', 'POLE3']",0.7982778670733303,0,0,6
61,Cells and molecules involved in local acute inflammatory response  WP4493,0.09787314845343513,6.103324808184143,14.184633688421794,"['C3', 'C6']",0.7982778670733303,0,0,2
62,Codeine and Morphine Metabolism WP1604,0.09787314845343513,6.103324808184143,14.184633688421794,"['ABCB1', 'ABCC2']",0.7982778670733303,0,0,2
63,Composition of Lipid Particles WP3601,0.09787314845343513,6.103324808184143,14.184633688421794,"['APOA1', 'LDLR']",0.7982778670733303,0,0,2
64,Nucleotide GPCRs WP80,0.09787314845343513,6.103324808184143,14.184633688421794,"['ADORA2A', 'LPAR6']",0.7982778670733303,0,0,2
65,Exercise-induced Circadian Regulation WP410,0.10402439512467972,1.697483307652799,3.8416251244837696,"['PER2', 'IDI1', 'DAZAP2', 'HSPA8', 'CLDN5', 'RBPMS', 'GSTP1', 'UCP3', 'G0S2', 'HERPUD1']",0.8353959116166586,0,0,10
66,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.11803336550667,2.180913348946136,4.660149333389205,"['MAPK11', 'CASP7', 'CASP8', 'BAX', 'FADD']",0.8801318658092608,0,0,5
67,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.11803336550667,2.180913348946136,4.660149333389205,"['MAPK11', 'ABCC2', 'SRXN1', 'GSTP1', 'FOS']",0.8801318658092608,0,0,5
68,Folate Metabolism WP176,0.11925387149225629,1.8590189520624303,3.953205073867391,"['SERPINA3', 'GPX2', 'AHCY', 'GPX4', 'RFK', 'APOA1', 'LDLR']",0.8801318658092608,0,0,7
69,Farnesoid X receptor pathway WP2879,0.12186571524496186,3.052200614124872,6.424380313082639,"['SLC10A1', 'SLCO2B1', 'FKBP5']",0.8801318658092608,0,0,3
70,Osteoclast Signaling WP12,0.12186571524496186,3.052200614124872,6.424380313082639,"['AIMP2', 'ATP6V1G1', 'GPR68']",0.8801318658092608,0,0,3
71,ERK Pathway in Huntington's Disease WP3853,0.12308357510359395,2.4421915002560164,5.1161266596388275,"['CASP7', 'RPS6KA5', 'EGF', 'HRAS']",0.8801318658092608,0,0,4
72,GDNF/RET signaling axis WP4830,0.12308357510359395,2.4421915002560164,5.1161266596388275,"['EYA1', 'SPRY1', 'SLIT2', 'GLI3']",0.8801318658092608,0,0,4
73,Hypertrophy Model WP516,0.12308357510359395,2.4421915002560164,5.1161266596388275,"['NR4A3', 'MSTN', 'IL1R1', 'IL18']",0.8801318658092608,0,0,4
74,Aryl Hydrocarbon Receptor Pathway WP2873,0.12950971567263186,1.928565647845909,3.9419869810761194,"['HSP90AA1', 'CDKN1B', 'TGFB1', 'AIP', 'BAX', 'AHR']",0.9060374726279965,0,0,6
75,Oncostatin M Signaling Pathway WP2374,0.1301777977913788,1.5631468247329048,3.1870282931635594,"['EGR1', 'CASP7', 'CDKN1B', 'PRKCH', 'PRKCD', 'RPS6', 'TIMP3', 'PTK2B', 'FOS', 'HRAS', 'LDLR']",0.9060374726279965,0,0,11
76,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.1363428033872021,1.7814102564102565,3.549607706589579,"['LDHA', 'EDN1', 'ANGPT2', 'PKM', 'ANGPT1', 'PGK1', 'BAX']",0.9258254165436359,0,0,7
77,Canonical and non-canonical Notch signaling WP3845,0.14008072436938437,2.0353483606557377,4.000551330064419,"['NOTCH1', 'MAML2', 'HEY1', 'PSEN2', 'DLL3']",0.9258254165436359,0,0,5
78,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.14088232781935991,inf,inf,['FMO5'],0.9258254165436359,0,0,1
79,Nicotine Metabolism WP1600,0.14088232781935991,inf,inf,['AOX1'],0.9258254165436359,0,0,1
80,Nuclear Receptors Meta-Pathway WP2882,0.141888952726994,1.2452810783340997,2.4316734998388165,"['ABCB1', 'CDKN1B', 'SRXN1', 'GSTP1', 'SLC7A11', 'AHR', 'CYP3A5', 'CYP3A7', 'CCND1', 'SLCO2B1', 'SLC39A7', 'CBR3', 'SLC39A3', 'SRGN', 'EGR1', 'HSP90AA1', 'GPX2', 'TGFB1', 'ABCC2', 'SLC10A1', 'SLC2A12', 'AIP', 'APOA1', 'TGFBR2', 'SLC2A9', 'TGFBR3', 'SLC6A7', 'B3GNT5', 'MAFF', 'SPINK13', 'BAX', 'SPRY1', 'ANGPTL4', 'FKBP5', 'FTL']",0.9258254165436359,0,0,35
81,ACE Inhibitor Pathway WP554,0.14821312287960375,4.068542199488491,7.767270275072296,"['TGFB1', 'ATP6AP2']",0.9286447919809782,0,0,2
82,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.14821312287960375,4.068542199488491,7.767270275072296,"['COX8A', 'GSTP1']",0.9286447919809782,0,0,2
83,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.14821312287960375,4.068542199488491,7.767270275072296,"['NOTCH1', 'DLL3']",0.9286447919809782,0,0,2
84,Genes controlling nephrogenesis WP4823,0.14943709296245625,1.8319835981547925,3.48238053792385,"['PDGFRB', 'EYA1', 'LAMB2', 'SLIT2', 'ETV4', 'GLI3']",0.9286447919809782,0,0,6
85,Development of ureteric collection system WP5053,0.15455176634256249,1.7100102564102564,3.1929759214541664,"['CCND1', 'SPRY1', 'SLIT2', 'ETV4', 'GLI3', 'FREM2', 'GLI2']",0.9348212036014902,0,0,7
86,IL-18 signaling pathway WP4754,0.1563038756430971,1.247615729354539,2.3155164622583277,"['EPB41', 'CD81', 'RGS16', 'COX17', 'PLD1', 'RND2', 'ACACB', 'CASP8', 'TMSB4X', 'TIMP3', 'FADD', 'TICAM2', 'USP5', 'IMP3', 'PRKCD', 'FN1', 'IL18', 'NDUFC1', 'FOS', 'BPGM', 'ACTA2', 'NR4A1', 'ARL4D', 'BMP2', 'RFX5', 'CYCS', 'BAX', 'LTB', 'NFKBIE', 'ITM2C', 'ARF6']",0.9348212036014902,0,0,31
87,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.15663678817803015,2.615952624652727,4.849519956764553,"['IDI1', 'HMGCS1', 'HMGCR']",0.9348212036014902,0,0,3
88,Osteoblast differentiation WP4787,0.15759437915120908,1.3773066010695807,2.544891783047619,"['PRKCH', 'NOTCH1', 'WNT5B', 'PRKCD', 'WNT8A', 'FGF1', 'GLI3', 'GLI2', 'DLL3', 'MAPK11', 'BMP2', 'HEY1', 'PRKD1', 'FGFR4', 'FGFR3', 'FGF10']",0.9348212036014902,0,0,16
89,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.1637616524030398,1.9079789959016393,3.452188912196795,"['BMP2', 'OMG', 'SOX8', 'ASCL1', 'GLI2']",0.9486084752678701,0,0,5
90,Vitamin B12 metabolism WP1533,0.1637616524030398,1.9079789959016393,3.452188912196795,"['SERPINA3', 'CUBN', 'APOA1', 'LRP2', 'LDLR']",0.9486084752678701,0,0,5
91,NRF2 pathway WP2884,0.16537044300646778,1.3493707323604232,2.4282833273861826,"['EGR1', 'HSP90AA1', 'GPX2', 'TGFB1', 'ABCC2', 'SRXN1', 'GSTP1', 'SLC2A12', 'SLC7A11', 'TGFBR2', 'SLC2A9', 'SLC6A7', 'MAFF', 'SLC39A7', 'SLC39A3', 'FTL', 'CBR3']",0.9486084752678701,0,0,17
92,Acute viral myocarditis WP4298,0.17116776334305914,1.4608338174181152,2.5785340320086885,"['CASP7', 'EDN1', 'CD4', 'SGCD', 'CASP8', 'ENDOG', 'TGFB1', 'CCND1', 'CYCS', 'BAX', 'SGCG']",0.9711910050551833,0,0,11
93,Parkinson's disease pathway WP2371,0.17380950593885325,1.6441025641025642,2.8768430593162826,"['MAPK11', 'CASP7', 'PINK1', 'CCNE2', 'HTRA2', 'CYCS', 'UBE2L6']",0.9735508242108349,0,0,7
94,"GPCRs, Class B Secretin-like WP334",0.17904382973992367,2.0348182283666154,3.5001409811462594,"['VIPR1', 'ADGRG2', 'ADGRE5', 'ADGRL4']",0.9735508242108349,0,0,4
95,Kynurenine Pathway and links to Cellular Senescence WP5044,0.17904382973992367,2.0348182283666154,3.5001409811462594,"['HAAO', 'AHR', 'KMO', 'ACMSD']",0.9735508242108349,0,0,4
96,miRNA targets in ECM and membrane receptors WP2911,0.17904382973992367,2.0348182283666154,3.5001409811462594,"['COL5A1', 'LAMB2', 'COL5A3', 'FN1']",0.9735508242108349,0,0,4
97,Inflammatory Response Pathway WP453,0.19398232111337252,2.2887666325486182,3.7535503897568754,"['IL5', 'LAMB2', 'FN1']",0.9861113478328654,0,0,3
98,Biogenic Amine Synthesis WP550,0.20227894500036714,3.051150895140665,4.876067490183296,"['GAD1', 'PAH']",0.9861113478328654,0,0,2
99,Cellular Proteostasis WP4918,0.20227894500036714,3.051150895140665,4.876067490183296,"['VBP1', 'PFDN5']",0.9861113478328654,0,0,2
100,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.20227894500036714,3.051150895140665,4.876067490183296,"['HSD11B1', 'STAR']",0.9861113478328654,0,0,2
101,Irinotecan pathway WP229,0.20227894500036714,3.051150895140665,4.876067490183296,"['ABCC2', 'CYP3A5']",0.9861113478328654,0,0,2
102,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.20227894500036714,3.051150895140665,4.876067490183296,"['AHCY', 'MAT2B']",0.9861113478328654,0,0,2
103,Peroxiredoxin 2 induced ovarian failure WP4873,0.20227894500036714,3.051150895140665,4.876067490183296,"['STAR', 'BAX']",0.9861113478328654,0,0,2
104,PTF1A related regulatory pathway WP4147,0.20227894500036714,3.051150895140665,4.876067490183296,"['NOTCH1', 'FGF10']",0.9861113478328654,0,0,2
105,Genotoxicity pathway WP4286,0.20929629393048807,1.446341727007457,2.262084762259179,"['IKBIP', 'ACTA2', 'PLK3', 'RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1', 'TRIM22', 'PHLDA3']",0.9861113478328654,0,0,9
106,Apoptosis Modulation by HSP70 WP384,0.2096903440794024,1.8781362007168458,2.93388048590805,"['CASP7', 'CASP8', 'CYCS', 'FADD']",0.9861113478328654,0,0,4
107,Constitutive Androstane Receptor Pathway WP2875,0.2096903440794024,1.8781362007168458,2.93388048590805,"['HSP90AA1', 'ABCB1', 'ABCC2', 'CYP3A5']",0.9861113478328654,0,0,4
108,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.2096903440794024,1.8781362007168458,2.93388048590805,"['CYP26A1', 'ABCD2', 'ABCB1', 'ABCC2']",0.9861113478328654,0,0,4
109,Nucleotide metabolism WP404,0.2096903440794024,1.8781362007168458,2.93388048590805,"['PRPS1', 'POLD1', 'NME2', 'OAZ1']",0.9861113478328654,0,0,4
110,Proteoglycan biosynthesis WP4784,0.2096903440794024,1.8781362007168458,2.93388048590805,"['CSGALNACT1', 'B4GALT7', 'PAPSS2', 'CHST3']",0.9861113478328654,0,0,4
111,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.2096903440794024,1.8781362007168458,2.93388048590805,"['ITGB4', 'BAX', 'BCL2L14', 'BCL2L2']",0.9861113478328654,0,0,4
112,Lung fibrosis WP3624,0.21638144760395522,1.5926280837028948,2.4378556640448634,"['EDN1', 'TGFB1', 'IL5', 'EGF', 'FAM13A', 'FGF1']",0.9999643490017845,0,0,6
113,Pathways in clear cell renal cell carcinoma WP4018,0.22201943332885843,1.3234053497942386,1.99171229834365,"['PDGFRB', 'TPI1', 'TGFB1', 'BHLHE41', 'ENO2', 'ACACB', 'LDHA', 'PKM', 'PGK1', 'ALDOC', 'ALDOA', 'GAPDH', 'PFKM']",0.9999643490017845,0,0,13
114,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.23258286139997303,1.4366341713699333,2.0953434726129365,"['IDI1', 'SQLE', 'HMGCS1', 'CYP51A1', 'MSMO1', 'HMGCR', 'DHCR7', 'FDFT1']",0.9999643490017845,0,0,8
115,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.23320111558657147,2.034288638689867,2.961627334583338,"['BMP2', 'SST', 'DKK1']",0.9999643490017845,0,0,3
116,Genes targeted by miRNAs in adipocytes WP1992,0.23320111558657147,2.034288638689867,2.961627334583338,"['KCNE1', 'TMSB4X', 'KCNQ1']",0.9999643490017845,0,0,3
117,IL1 and megakaryocytes in obesity WP2865,0.23320111558657147,2.034288638689867,2.961627334583338,"['IL1R1', 'IL18', 'TIMP2']",0.9999643490017845,0,0,3
118,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.23320111558657147,2.034288638689867,2.961627334583338,"['TGFB1', 'STAT6', 'TGFBR2']",0.9999643490017845,0,0,3
119,Ferroptosis WP4313,0.23702290183246477,1.4736516357206013,2.1214666995008993,"['MAP1LC3A', 'GPX4', 'ACSL5', 'SAT2', 'SLC7A11', 'CP', 'FTL']",0.9999643490017845,0,0,7
120,Hedgehog Signaling Pathway WP4249,0.23702290183246477,1.4736516357206013,2.1214666995008993,"['EVC', 'CCND1', 'HHIP', 'GAS1', 'LRP2', 'GLI3', 'GLI2']",0.9999643490017845,0,0,7
121,Alpha 6 Beta 4 signaling pathway WP244,0.2406633420837881,1.52614044079959,2.1737676644089685,"['LAMB3', 'ITGB4', 'LAMB2', 'PRKCD', 'GAB1', 'HRAS']",0.9999643490017845,0,0,6
122,One-carbon metabolism WP241,0.2416655257206552,1.7438373198741863,2.4765988672130064,"['AHCY', 'CHDH', 'GLRX', 'MAT2B']",0.9999643490017845,0,0,4
123,Photodynamic therapy-induced unfolded protein response WP3613,0.24275284699722194,1.6063147109577223,2.2740781186079033,"['XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR']",0.9999643490017845,0,0,5
124,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.2580230160790828,2.440716112531969,3.3064539540641986,"['CYP51A1', 'DHCR7']",0.9999643490017845,0,0,2
125,Dual hijack model of Vif in HIV infection WP3300,0.2580230160790828,2.440716112531969,3.3064539540641986,"['ELOB', 'RUNX1']",0.9999643490017845,0,0,2
126,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.2580230160790828,2.440716112531969,3.3064539540641986,"['CHI3L1', 'BAX']",0.9999643490017845,0,0,2
127,NAD Biosynthesis II (from tryptophan) WP2485,0.2580230160790828,2.440716112531969,3.3064539540641986,"['HAAO', 'KMO']",0.9999643490017845,0,0,2
128,Role of Osx and miRNAs in tooth development WP3971,0.2580230160790828,2.440716112531969,3.3064539540641986,"['NOTCH1', 'DKK1']",0.9999643490017845,0,0,2
129,Sulfation Biotransformation Reaction WP692,0.2580230160790828,2.440716112531969,3.3064539540641986,"['SULT4A1', 'PAPSS2']",0.9999643490017845,0,0,2
130,COVID-19 adverse outcome pathway WP4891,0.26192560486833916,6.100715746421268,8.173096956938918,['IL7'],0.9999643490017845,0,0,1
131,Hematopoietic Stem Cell Differentiation WP2849,0.27106362865676664,1.5258709016393444,1.9918744591697866,"['CIITA', 'NOTCH1', 'IL5', 'FOS', 'RUNX1']",0.9999643490017845,0,0,5
132,Matrix Metalloproteinases WP129,0.27363781885889726,1.8307062436028658,2.3725035293213366,"['MMP26', 'TIMP2', 'TIMP3']",0.9999643490017845,0,0,3
133,NOTCH1 regulation of endothelial cell calcification WP3413,0.27363781885889726,1.8307062436028658,2.3725035293213366,"['NOTCH1', 'FGFR3', 'DLL3']",0.9999643490017845,0,0,3
134,Cytosolic DNA-sensing pathway WP4655,0.2743454486974232,1.3565931246793228,1.754573058012129,"['CASP8', 'TRADD', 'POLR1C', 'IL18', 'POLR2E', 'FADD', 'POLR2K', 'POLR2L']",0.9999643490017845,0,0,8
135,Ovarian infertility WP34,0.2746341005335879,1.6274449564772144,2.1031725229549574,"['EGR1', 'CDKN1B', 'MSH5', 'PRLR']",0.9999643490017845,0,0,4
136,Oxysterols derived from cholesterol WP4545,0.30002232467053513,1.4530884074941453,1.7493707965275493,"['CYP39A1', 'INSIG1', 'ACOT11', 'DHCR7', 'ACOT6']",0.9999643490017845,0,0,5
137,Pre-implantation embryo WP3527,0.30002232467053513,1.4530884074941453,1.7493707965275493,"['EGR1', 'ZFP36', 'DDIT3', 'SOX8', 'ZFP36L2']",0.9999643490017845,0,0,5
138,Adipogenesis WP236,0.30179917289651287,1.1914401678792677,1.4273375448519308,"['GDF10', 'TGFB1', 'WNT5B', 'GADD45A', 'ASIP', 'EBF1', 'AHR', 'PRLR', 'SFRP4', 'CYP26A1', 'BMP2', 'DDIT3', 'NDN', 'ID3', 'STAT6', 'PCK2']",0.9999643490017845,0,0,16
139,Myometrial relaxation and contraction pathways WP289,0.30469881572274443,1.1632126262998745,1.382398502676093,"['RYR1', 'OXTR', 'PRKCH', 'IGFBP5', 'RGS16', 'PRKCD', 'FOS', 'ACTG1', 'RGS4', 'ACTA2', 'RGS5', 'ACTC1', 'PRKAR1A', 'GNG4', 'MAFF', 'CRH', 'CALM3', 'PRKD1', 'IGFBP6', 'CORIN']",0.9999643490017845,0,0,20
140,Metabolic reprogramming in colon cancer WP4290,0.3063442074642732,1.3351602564102565,1.5795559315671845,"['LDHA', 'PKM', 'PGAM1', 'PGK1', 'PYCR1', 'SLC16A3', 'GAPDH']",0.9999643490017845,0,0,7
141,TGF-beta Receptor Signaling WP560,0.3063442074642732,1.3351602564102565,1.5795559315671845,"['TGFBR3', 'TGFB1', 'EGF', 'FST', 'FOS', 'HRAS', 'TGFBR2']",0.9999643490017845,0,0,7
142,Blood Clotting Cascade WP272,0.31390025523569054,2.033759590792839,2.356476566774324,"['F8A1', 'F5']",0.9999643490017845,0,0,2
143,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.3146980623892547,1.6641388294407742,1.9239801820439981,"['EGF', 'CD81', 'PDLIM5']",0.9999643490017845,0,0,3
144,Mammalian disorder of sexual development WP4842,0.3146980623892547,1.6641388294407742,1.9239801820439981,"['MAPK11', 'FST', 'SOX8']",0.9999643490017845,0,0,3
145,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.3146980623892547,1.6641388294407742,1.9239801820439981,"['TGFB1', 'FN1', 'VIM']",0.9999643490017845,0,0,3
146,Oxidative Damage WP3941,0.3174700119707144,1.3562275756022553,1.5560974314029565,"['C1QA', 'CDKN1B', 'GADD45A', 'C5AR1', 'CYCS', 'NFKBIE']",0.9999643490017845,0,0,6
147,Gastric Cancer Network 1 WP2361,0.3422749729993924,1.4357398873527907,1.5393153837050113,"['NOTCH1', 'GATD3B', 'GATD3A', 'KIF15']",0.9999643490017845,0,0,4
148,IL-7 signaling pathway WP205,0.3422749729993924,1.4357398873527907,1.5393153837050113,"['CDKN1B', 'CCND1', 'IL7', 'PTK2B']",0.9999643490017845,0,0,4
149,Type II interferon signaling (IFNG) WP619,0.3422749729993924,1.4357398873527907,1.5393153837050113,"['CIITA', 'PRKCD', 'HLA-B', 'IFIT2']",0.9999643490017845,0,0,4
150,Unfolded protein response WP4925,0.3422749729993924,1.4357398873527907,1.5393153837050113,"['XBP1', 'CASP8', 'HSPA5', 'DDIT3']",0.9999643490017845,0,0,4
151,Bladder cancer WP2828,0.34392041991983613,1.307681042688731,1.39574680395746,"['RPS6KA5', 'CCND1', 'EGF', 'DAPK2', 'HRAS', 'FGFR3']",0.9999643490017845,0,0,6
152,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.34392041991983613,1.307681042688731,1.39574680395746,"['IFITM3', 'MAPK11', 'IFITM2', 'IFI27', 'DDIT3', 'FOS']",0.9999643490017845,0,0,6
153,"GPCRs, Other WP117",0.3545601127284475,1.2564102564102564,1.3027433710074985,"['ADGRV1', 'ADORA2A', 'GNRHR', 'GPR83', 'MCHR2', 'NTSR1', 'GPR135']",0.9999643490017845,0,0,7
154,VEGFA-VEGFR2 Signaling Pathway WP3888,0.3545674136673111,1.065725368350155,1.105004579755655,"['TRAF3IP2', 'RPL10A', 'ETS1', 'RPL7', 'HERPUD1', 'ACTG1', 'TUBB8', 'TUBA1C', 'RPS6KA5', 'RPL18A', 'CCND1', 'TMSB4X', 'RPLP2', 'ATP6V1E1', 'HRAS', 'DUSP5', 'HSP90AA1', 'TRPC3', 'PRKCD', 'RPS6', 'GAB1', 'RPL13A', 'DKK1', 'RHOJ', 'RPL27', 'PRKD1', 'RPL26', 'ALDOA', 'GAPDH', 'FJX1', 'ARF6', 'KANK1', 'SET', 'EPB41', 'ACACB', 'APOLD1', 'LDHA', 'PGK1', 'DNAJB9', 'PTK2B', 'STAT6', 'IGFBP7', 'MYH11', 'FADD', 'CCT7', 'EGR1', 'SDF2L1', 'FN1', 'BMX', 'RAB11A', 'NR4A1', 'BMP2', 'NR4A3', 'CYCS', 'PTPN6', 'CALR']",0.9999643490017845,0,0,56
155,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.35585644326729143,1.5253326509723644,1.5760162192853744,"['HPGD', 'TRPA1', 'ALOX12']",0.9999643490017845,0,0,3
156,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.35585644326729143,1.5253326509723644,1.5760162192853744,"['HMGCS1', 'HMGCR', 'LDLR']",0.9999643490017845,0,0,3
157,Glucocorticoid Receptor Pathway WP2880,0.362742260752565,1.2205233453052848,1.2376872262683554,"['SRGN', 'TGFBR3', 'HSP90AA1', 'MGAM', 'B3GNT5', 'SPINK13', 'SPRY1', 'ANGPTL4']",0.9999643490017845,0,0,8
158,Synaptic Vesicle Pathway WP2267,0.362742260752565,1.2205233453052848,1.2376872262683554,"['RAB3A', 'SLC32A1', 'SYN3', 'SLC25A4', 'CPLX1', 'SLC18A2', 'AP2M1', 'CPLX3']",0.9999643490017845,0,0,8
159,let-7 inhibition of ES cell reprogramming WP3299,0.3659222684404606,3.0501022494887526,3.0663725607368866,['EGR1'],0.9999643490017845,0,0,1
160,MED and Pseudoachondroplasia genes WP4789,0.3659222684404606,3.0501022494887526,3.0663725607368866,['COL9A2'],0.9999643490017845,0,0,1
161,Steroid Biosynthesis WP496,0.3659222684404606,3.0501022494887526,3.0663725607368866,['HSD17B1'],0.9999643490017845,0,0,1
162,EDA signaling in hair follicle development WP3930,0.3687672542307619,1.7430763609791742,1.7388748171031123,"['LTB', 'DKK1']",0.9999643490017845,0,0,2
163,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.3745491611122333,1.1736004108885465,1.1525134090492963,"['PSMD8', 'TUBB8', 'TUBA1C', 'HSPA8', 'TUBB6', 'CASP8', 'HSPA5', 'UBE2L6', 'STUB1', 'TUBA8']",0.9999643490017845,0,0,10
164,7-oxo-C and 7beta-HC pathways WP5064,0.376358814681864,1.355862775217614,1.324965776004164,"['HSD11B1', 'ACOT11', 'DHCR7', 'ACOT6']",0.9999643490017845,0,0,4
165,Methionine De Novo and Salvage Pathway WP3580,0.3966593423028974,1.4078812691914022,1.3018360569679306,"['AHCY', 'CHDH', 'MAT2B']",0.9999643490017845,0,0,3
166,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.40340942594701,1.1864102564102563,1.0770271310699908,"['TGFBR3', 'TGFB1', 'EGF', 'FST', 'FOS', 'HRAS', 'TGFBR2']",0.9999643490017845,0,0,7
167,Cannabinoid receptor signaling WP3869,0.4102668767531887,1.284393780149298,1.1443273145791089,"['MAPK11', 'ADORA2A', 'PRKAR1A', 'AHR']",0.9999643490017845,0,0,4
168,Proteasome Degradation WP183,0.41171368446458717,1.1440580082135523,1.0152680940014651,"['PSMD8', 'PSMB6', 'H2AFZ', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'PSMB10', 'HLA-E']",0.9999643490017845,0,0,9
169,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.41463981767111585,1.1299435028248588,0.9947401636485225,"['IDI1', 'SQLE', 'RBP4', 'HMGCS1', 'INSIG1', 'CYP51A1', 'HMGCR', 'ACSS1', 'LDLR', 'FDFT1']",0.9999643490017845,0,0,10
170,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.4217998526191089,1.5250639386189258,1.316472342902505,"['NOTCH1', 'TCF7']",0.9999643490017845,0,0,2
171,Cysteine and methionine catabolism WP4504,0.4217998526191089,1.5250639386189258,1.316472342902505,"['AHCY', 'GOT1']",0.9999643490017845,0,0,2
172,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.4217998526191089,1.5250639386189258,1.316472342902505,"['MAFF', 'MAFK']",0.9999643490017845,0,0,2
173,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.42392215900180746,1.1808336502372645,1.0133978480384007,"['CASP8', 'TGFB1', 'TRADD', 'CXCL17', 'FADD', 'IFIT2']",0.9999643490017845,0,0,6
174,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.43296096191693006,1.1206155973683107,0.9380759590580283,"['YAP1', 'MAPK11', 'CASP7', 'ANGPT2', 'ANGPT1', 'FN1', 'BAX', 'HRAS', 'ANGPTL1']",0.9999643490017845,0,0,9
175,Senescence and Autophagy in Cancer WP615,0.437203538001665,1.0927675248436481,0.9041082385051034,"['GABARAPL2', 'GABARAPL1', 'BMP2', 'TGFB1', 'CDKN1B', 'MAP1LC3A', 'IGFBP5', 'FN1', 'IGFBP7', 'HRAS', 'GABARAP', 'SLC39A3']",0.9999643490017845,0,0,12
176,Effects of nitric oxide WP1995,0.4552719350883695,2.033231083844581,1.5998689812765925,['AOX1'],0.9999643490017845,0,0,1
177,Gene regulatory network modelling somitogenesis  WP2854,0.4552719350883695,2.033231083844581,1.5998689812765925,['NOTCH1'],0.9999643490017845,0,0,1
178,Platelet-mediated interactions with vascular and circulating cells WP4462,0.4552719350883695,2.033231083844581,1.5998689812765925,['TGFB1'],0.9999643490017845,0,0,1
179,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.4552719350883695,2.033231083844581,1.5998689812765925,['SLIT2'],0.9999643490017845,0,0,1
180,Vitamin B6-dependent and responsive disorders WP4228,0.4552719350883695,2.033231083844581,1.5998689812765925,['PNPO'],0.9999643490017845,0,0,1
181,Breast cancer pathway WP4262,0.4705374498702017,1.0475632614807873,0.7897367058169876,"['SHC4', 'NOTCH1', 'SHC3', 'WNT5B', 'GADD45A', 'EGF', 'TCF7', 'FOS', 'FGF1', 'DLL3', 'SFRP4', 'FRAT2', 'CCND1', 'HEY1', 'BAX', 'HRAS', 'FGF10']",0.9999643490017845,0,0,17
182,Alanine and aspartate metabolism WP106,0.47242594818307665,1.3554987212276215,1.0164536110204172,"['GOT1', 'GAD1']",0.9999643490017845,0,0,2
183,Cancer immunotherapy by PD-1 blockade WP4585,0.47242594818307665,1.3554987212276215,1.0164536110204172,"['HLA-A', 'PDCD1LG2']",0.9999643490017845,0,0,2
184,Glutathione metabolism WP100,0.47242594818307665,1.3554987212276215,1.0164536110204172,"['GPX2', 'GPX4']",0.9999643490017845,0,0,2
185,Homologous recombination WP186,0.47242594818307665,1.3554987212276215,1.0164536110204172,"['POLD4', 'POLD1']",0.9999643490017845,0,0,2
186,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.47242594818307665,1.3554987212276215,1.0164536110204172,"['TGFB1', 'CCND1']",0.9999643490017845,0,0,2
187,RalA downstream regulated genes WP2290,0.47242594818307665,1.3554987212276215,1.0164536110204172,"['EXOC8', 'HRAS']",0.9999643490017845,0,0,2
188,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.47242594818307665,1.3554987212276215,1.0164536110204172,"['PTTG1', 'ANAPC11']",0.9999643490017845,0,0,2
189,Serotonin and anxiety-related events WP3944,0.47242594818307665,1.3554987212276215,1.0164536110204172,"['CRH', 'FOS']",0.9999643490017845,0,0,2
190,Pathways Regulating Hippo Signaling WP4540,0.4734550598070094,1.0609142729406504,0.7932437787079619,"['PDGFRB', 'PRKCH', 'PRKD3', 'PRKAR1A', 'CDH20', 'PRKCD', 'TCF7', 'CDH22', 'FGFR4', 'FGFR3', 'CDH18', 'CDH19']",0.9999643490017845,0,0,12
191,Purinergic signaling WP4900,0.4757358132262522,1.219959058341863,0.9062985482770248,"['ADORA2A', 'LPAR6', 'P2RY14']",0.9999643490017845,0,0,3
192,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.4766660450801625,1.1618755028893277,0.8608790456864257,"['TGFBR3', 'TGFB1', 'HRAS', 'TGFBR2']",0.9999643490017845,0,0,4
193,Endometrial cancer WP4155,0.4960498876166355,1.0556981519507187,0.7401275697182087,"['CCND1', 'EGF', 'GADD45A', 'TCF7', 'BAX', 'FOS', 'FGF1', 'HRAS', 'FGFR3']",0.9999643490017845,0,0,9
194,DNA damage response WP707,0.49790335623513166,1.0607892564748924,0.7397406290877961,"['CDKN1B', 'CASP8', 'CCND1', 'CCNE2', 'GADD45A', 'CYCS', 'BAX', 'RAD9A']",0.9999643490017845,0,0,8
195,p38 MAPK Signaling Pathway WP400,0.5052517487756053,1.08917593676815,0.743578736329945,"['RPS6KA5', 'TRADD', 'DDIT3', 'HRAS', 'HMGN1']",0.9999643490017845,0,0,5
196,Tryptophan metabolism WP465,0.5087830694464949,1.1089698831634316,0.7493681481957196,"['HAAO', 'AOX1', 'CYP2C18', 'ACMSD']",0.9999643490017845,0,0,4
197,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.513442365003672,1.1436156601842375,0.7623542071360566,"['LDHA', 'RPS6', 'ACACB']",0.9999643490017845,0,0,3
198,Kallmann's Syndrome WP5074,0.513442365003672,1.1436156601842375,0.7623542071360566,"['PLXND1', 'CHD7', 'ASCL1']",0.9999643490017845,0,0,3
199,Biomarkers for pyrimidine metabolism disorders WP4584,0.5202708886326225,1.219846547314578,0.797054642458311,"['NT5C', 'DPYD']",0.9999643490017845,0,0,2
200,Hedgehog Signaling Pathway Netpath WP47,0.5202708886326225,1.219846547314578,0.797054642458311,"['GLI3', 'GLI2']",0.9999643490017845,0,0,2
201,Overview of nanoparticle effects WP3287,0.5202708886326225,1.219846547314578,0.797054642458311,"['FN1', 'BAX']",0.9999643490017845,0,0,2
202,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5234251478388833,1.0412883051907442,0.6740896915338683,"['BEX3', 'CASP7', 'CDKN1B', 'HSPA5', 'PTK2B', 'VIM', 'ETS1']",0.9999643490017845,0,0,7
203,Phosphodiesterases in neuronal function WP4222,0.5234251478388833,1.0412883051907442,0.6740896915338683,"['ADCY10', 'PDE10A', 'ADORA2A', 'PDE3A', 'PDE6C', 'PDE5A', 'PDE6B']",0.9999643490017845,0,0,7
204,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.5320365919125771,1.524795501022495,0.9622115429279712,['CYP2C18'],0.9999643490017845,0,0,1
205,EV release from cardiac cells and their functional effects WP3297,0.5320365919125771,1.524795501022495,0.9622115429279712,['RGS16'],0.9999643490017845,0,0,1
206,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.5320365919125771,1.524795501022495,0.9622115429279712,['ABCB1'],0.9999643490017845,0,0,1
207,Metabolism of alpha-linolenic acid WP4586,0.5320365919125771,1.524795501022495,0.9622115429279712,['ALOX12'],0.9999643490017845,0,0,1
208,miR-517 relationship with ARCN1 and USP1 WP3596,0.5320365919125771,1.524795501022495,0.9622115429279712,['ARCN1'],0.9999643490017845,0,0,1
209,Mitochondrial fatty acid synthesis pathway WP4317,0.5320365919125771,1.524795501022495,0.9622115429279712,['HSD17B12'],0.9999643490017845,0,0,1
210,Tgif disruption of Shh signaling WP3674,0.5320365919125771,1.524795501022495,0.9622115429279712,['GLI3'],0.9999643490017845,0,0,1
211,The alternative pathway of fetal androgen synthesis WP4524,0.5320365919125771,1.524795501022495,0.9622115429279712,['STAR'],0.9999643490017845,0,0,1
212,Vitamin D Metabolism WP1531,0.5320365919125771,1.524795501022495,0.9622115429279712,['DHCR7'],0.9999643490017845,0,0,1
213,DNA Replication WP466,0.5330674806500191,1.05152981910684,0.6615250406598419,"['POLD4', 'POLD1', 'RPA3', 'POLE2', 'GMNN']",0.9999643490017845,0,0,5
214,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5330674806500191,1.05152981910684,0.6615250406598419,"['CASP7', 'CASP8', 'CYCS', 'FADD', 'ACTG1']",0.9999643490017845,0,0,5
215,Apoptosis WP254,0.5370340008523804,1.0164271047227926,0.6319065004899534,"['CASP7', 'CASP8', 'CRADD', 'TRADD', 'CYCS', 'BAX', 'FADD', 'NFKBIE', 'BCL2L2']",0.9999643490017845,0,0,9
216,PI3K-Akt signaling pathway WP4172,0.5370840840003422,0.9961610506164962,0.6192143224240533,"['CDKN1B', 'ITGB4', 'FGF1', 'THBS4', 'GYS2', 'GHR', 'CCND1', 'GNG4', 'NTF3', 'HRAS', 'PCK2', 'PDGFRB', 'HSP90AA1', 'ANGPT2', 'ANGPT1', 'LAMB3', 'EGF', 'LAMB2', 'RPS6', 'LAMB4', 'FN1', 'VEGFB', 'VEGFC', 'PRLR', 'CCNE2', 'LPAR6', 'IL7', 'COL6A6', 'COL9A2', 'FGFR4', 'SGK2', 'FGFR3', 'FGF10']",0.9999643490017845,0,0,33
217,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5399752406059907,1.0606647521093524,0.653615552192923,"['ACTA2', 'CASP8', 'TGFB1', 'BAX']",0.9999643490017845,0,0,4
218,miRNA regulation of DNA damage response WP1530,0.5413601466911974,1.0164186762442278,0.6237461736145903,"['CDKN1B', 'CASP8', 'CCND1', 'CCNE2', 'GADD45A', 'CYCS', 'BAX', 'RAD9A']",0.9999643490017845,0,0,8
219,Urea cycle and associated pathways WP4595,0.5496488008852564,1.0762538382804503,0.6441118215017609,"['SLC25A15', 'GOT1', 'PYCR1']",0.9999643490017845,0,0,3
220,Eukaryotic Transcription Initiation WP405,0.5525392546805118,1.0164018452075858,0.6029608786548427,"['TAF13', 'POLR2E', 'POLR1E', 'TAF7', 'POLR2I', 'POLR2K']",0.9999643490017845,0,0,6
221,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.5626371633923724,0.9854339375204908,0.5667430899586904,"['EGR1', 'VIPR1', 'CAV3', 'CDCA7L', 'ATP1A3', 'SSTR1', 'ASCL1', 'GCK', 'PRKAR1A', 'SST', 'KCNQ1', 'PAH', 'TAC1', 'ALDOA', 'GAPDH', 'SLC25A4']",0.9999643490017845,0,0,16
222,Fatty acid transporters WP5061,0.5651132359868275,1.108858405022088,0.6328578152356634,"['FABP6', 'ACSL5']",0.9999643490017845,0,0,2
223,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.5651132359868275,1.108858405022088,0.6328578152356634,"['CCND1', 'TULP3']",0.9999643490017845,0,0,2
224,Major receptors targeted by epinephrine and norepinephrine WP4589,0.5651132359868275,1.108858405022088,0.6328578152356634,"['ADCY10', 'ADRA2C']",0.9999643490017845,0,0,2
225,miRNAs involved in DNA damage response WP1545,0.5651132359868275,1.108858405022088,0.6328578152356634,"['CDKN1B', 'CCND1']",0.9999643490017845,0,0,2
226,Phytochemical activity on NRF2 transcriptional activation WP3,0.5651132359868275,1.108858405022088,0.6328578152356634,"['AIMP2', 'SLC7A11']",0.9999643490017845,0,0,2
227,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.5651132359868275,1.108858405022088,0.6328578152356634,"['LDHA', 'HLA-DRA']",0.9999643490017845,0,0,2
228,Pyrimidine metabolism and related diseases WP4225,0.5651132359868275,1.108858405022088,0.6328578152356634,"['NT5C', 'DPYD']",0.9999643490017845,0,0,2
229,Tryptophan catabolism leading to NAD+ production WP4210,0.5651132359868275,1.108858405022088,0.6328578152356634,"['HAAO', 'KMO']",0.9999643490017845,0,0,2
230,Type II diabetes mellitus WP1584,0.5651132359868275,1.108858405022088,0.6328578152356634,"['SURF1', 'PRKCD']",0.9999643490017845,0,0,2
231,GABA receptor Signaling WP4159,0.5701231901630993,1.0163850486431132,0.5711096234239925,"['SLC32A1', 'GAD1', 'GABRD', 'AP2M1']",0.9999643490017845,0,0,4
232,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.5767224559065972,0.9888484076080181,0.5442563693814616,"['PPP1R14B', 'XBP1', 'MAP1LC3A', 'PPP1R11', 'HSPA5', 'DDIT3']",0.9999643490017845,0,0,6
233,Small cell lung cancer WP4658,0.5786625886925778,0.975547557840617,0.533659360351292,"['CDKN1B', 'CASP8', 'CCND1', 'CCNE2', 'LAMB3', 'LAMB2', 'GADD45A', 'LAMB4', 'FN1', 'CYCS', 'BAX', 'CKS1B']",0.9999643490017845,0,0,12
234,Endoderm differentiation WP2853,0.5812929533456442,0.9728948002717094,0.5277958441666615,"['DUSP4', 'DUSP5', 'DUSP2', 'NOTCH1', 'TGFB1', 'TCF7', 'SLC2A12', 'PBX3', 'WNT8A', 'DKK1', 'GLI2', 'NME1', 'TRIM5', 'TCEAL2', 'TOX']",0.9999643490017845,0,0,15
235,Angiogenesis WP1539,0.5842110824767508,1.0163766632548619,0.5462952593954395,"['ANGPT1', 'TIMP2', 'TIMP3']",0.9999643490017845,0,0,3
236,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.5842110824767508,1.0163766632548619,0.5462952593954395,"['TGFBR3', 'ANGPT2', 'TGFBR2']",0.9999643490017845,0,0,3
237,Microglia Pathogen Phagocytosis Pathway WP3937,0.5842110824767508,1.0163766632548619,0.5462952593954395,"['C1QA', 'HCK', 'PTPN6']",0.9999643490017845,0,0,3
238,Nephrotic syndrome WP4758,0.586421782442205,0.9835239291380222,0.5249224406952385,"['CUBN', 'INF2', 'ITGB4', 'LAMB2', 'GPC5']",0.9999643490017845,0,0,5
239,22q11.2 copy number variation syndrome WP4657,0.595367344457546,0.9626302259504803,0.4991975850023483,"['SLC7A4', 'ACTA2', 'CLDN5', 'CYP26A1', 'RANBP1', 'MRPL40', 'ACTC1', 'SERPIND1', 'THAP7', 'RCC1', 'RAN', 'FGF10']",0.9999643490017845,0,0,12
240,Head and Neck Squamous Cell Carcinoma WP4674,0.5959917100468084,0.9626877769372095,0.49821838170170146,"['CASP8', 'NOTCH1', 'CCND1', 'RPS6', 'GAB1', 'FADD', 'HRAS', 'FGFR3', 'TGFBR2']",0.9999643490017845,0,0,9
241,T-cell receptor (TCR) signaling pathway WP69,0.5959917100468084,0.9626877769372095,0.49821838170170146,"['CD4', 'TGFB1', 'FYB1', 'PRKCD', 'PTK2B', 'FOS', 'CD247', 'VIM', 'HRAS']",0.9999643490017845,0,0,9
242,Insulin signaling in adipocytes (diabetic condition) WP3635,0.5979880717387378,1.2197341513292435,0.627168360771429,['RPS6'],0.9999643490017845,0,0,1
243,Insulin signaling in adipocytes (normal condition) WP3634,0.5979880717387378,1.2197341513292435,0.627168360771429,['RPS6'],0.9999643490017845,0,0,1
244,Methylation Pathways WP704,0.5979880717387378,1.2197341513292435,0.627168360771429,['MAT2B'],0.9999643490017845,0,0,1
245,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.5979880717387378,1.2197341513292435,0.627168360771429,['STRADB'],0.9999643490017845,0,0,1
246,miRNA Biogenesis WP2338,0.5979880717387378,1.2197341513292435,0.627168360771429,['RAN'],0.9999643490017845,0,0,1
247,Molybdenum cofactor (Moco) biosynthesis WP4507,0.5979880717387378,1.2197341513292435,0.627168360771429,['AOX1'],0.9999643490017845,0,0,1
248,Osteoblast Signaling WP322,0.5979880717387378,1.2197341513292435,0.627168360771429,['PDGFRB'],0.9999643490017845,0,0,1
249,Somatic sex determination WP4814,0.5979880717387378,1.2197341513292435,0.627168360771429,['SOX8'],0.9999643490017845,0,0,1
250,Tamoxifen metabolism WP691,0.5979880717387378,1.2197341513292435,0.627168360771429,['CYP3A5'],0.9999643490017845,0,0,1
251,Urea cycle and related diseases WP4571,0.5979880717387378,1.2197341513292435,0.627168360771429,['SLC25A15'],0.9999643490017845,0,0,1
252,PDGFR-beta pathway WP3972,0.5991320267956911,0.9756477214541731,0.49979827121484893,"['PDGFRB', 'STAT6', 'FOS', 'HRAS']",0.9999643490017845,0,0,4
253,Tumor suppressor activity of SMARCB1 WP4204,0.5991320267956911,0.9756477214541731,0.49979827121484893,"['H3F3B', 'DPF3', 'GLI3', 'GLI2']",0.9999643490017845,0,0,4
254,Nucleotide Excision Repair WP4753,0.6002322611706562,0.9627451509347433,0.49142228384166,"['POLE4', 'POLD4', 'POLD1', 'RPA3', 'POLE2', 'POLE3']",0.9999643490017845,0,0,6
255,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.6035116234239553,0.9563878912262699,0.48296630073025115,"['CDKN1B', 'INF2', 'NOTCH1', 'TGFB1', 'ITGB4', 'LAMB2', 'VIM', 'DKK1']",0.9999643490017845,0,0,8
256,Differentiation of white and brown adipocyte WP2895,0.6068490670395865,1.0163682864450128,0.5076507255139687,"['BMP2', 'ZIC1']",0.9999643490017845,0,0,2
257,Riboflavin and CoQ disorders WP5037,0.6068490670395865,1.0163682864450128,0.5076507255139687,"['SLC52A2', 'RFK']",0.9999643490017845,0,0,2
258,Serotonin and anxiety WP3947,0.6068490670395865,1.0163682864450128,0.5076507255139687,"['CRH', 'FOS']",0.9999643490017845,0,0,2
259,TP53 network WP1742,0.6068490670395865,1.0163682864450128,0.5076507255139687,"['GADD45A', 'BAX']",0.9999643490017845,0,0,2
260,Calcium Regulation in the Cardiac Cell WP536,0.6156498770798333,0.9506526056937482,0.46113957940202105,"['RYR1', 'PRKCH', 'RGS16', 'CHRM5', 'PRKCD', 'ATP1B2', 'ATP1B1', 'RGS4', 'GJD2', 'RGS5', 'PLN', 'PRKAR1A', 'GNG4', 'GJA9', 'CALM3', 'PRKD1', 'CALR']",0.9999643490017845,0,0,17
261,Physiological and pathological hypertrophy of the heart WP1528,0.6170298370090346,0.9628023487582826,0.46487746230874166,"['MAPK11', 'EDN1', 'FOS']",0.9999643490017845,0,0,3
262,Prader-Willi and Angelman Syndrome WP3998,0.6230190085906032,0.9379805228088159,0.44383198164025256,"['GABRR2', 'MAGEL2', 'CCND1', 'NDN', 'TYR', 'GABRD']",0.9999643490017845,0,0,6
263,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.626929436697188,0.9380440348182284,0.43799272690741997,"['PRKCH', 'STAR', 'PRKCD', 'HRAS']",0.9999643490017845,0,0,4
264,miRNA regulation of prostate cancer signaling pathways WP3981,0.626929436697188,0.9380440348182284,0.43799272690741997,"['PDGFRB', 'CDKN1B', 'CCND1', 'TCF7']",0.9999643490017845,0,0,4
265,Aryl Hydrocarbon Receptor Netpath WP2586,0.6362694111250989,0.923761177347243,0.41766309986399697,"['HSP90AA1', 'CDKN1B', 'AIP', 'AHR', 'HRAS']",0.9999643490017845,0,0,5
266,One-carbon metabolism and related pathways WP3940,0.6362694111250989,0.923761177347243,0.41766309986399697,"['GPX2', 'GPX4', 'CHDH', 'GAD1', 'PLD1']",0.9999643490017845,0,0,5
267,Ebola Virus Pathway on Host WP4217,0.636949042312187,0.932201646090535,0.4204841162368526,"['VPS18', 'CAV3', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'ASGR1', 'ACTG1', 'HLA-E', 'VPS11', 'HLA-DRA', 'FLNC', 'CLEC4G']",0.9999643490017845,0,0,13
268,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.642454868291459,0.9201428889512764,0.4071252343584314,"['SFRP4', 'FRAT2', 'CCND1', 'WNT5B', 'TCF7', 'NOTUM', 'DKK1', 'CXXC4']",0.9999643490017845,0,0,8
269,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.642454868291459,0.9201428889512764,0.4071252343584314,"['EGR1', 'CDKN1B', 'APEX1', 'RPS6', 'FOS', 'PLD1', 'HRAS', 'TSHR']",0.9999643490017845,0,0,8
270,Modulators of TCR signaling and T cell activation WP5072,0.6450419310204998,0.9144541260891851,0.4009332258603491,"['CDKN1B', 'NDUFB10', 'ELOB', 'PTPN6', 'CD247', 'ZFP36L1']",0.9999643490017845,0,0,6
271,Canonical and non-canonical TGF-B signaling WP3874,0.6454632837228411,0.9381074168797954,0.4106911854466532,"['TGFB1', 'TGFBR2']",0.9999643490017845,0,0,2
272,Eicosanoid Synthesis WP167,0.6454632837228411,0.9381074168797954,0.4106911854466532,"['PTGES2', 'ALOX12']",0.9999643490017845,0,0,2
273,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.6454632837228411,0.9381074168797954,0.4106911854466532,"['CCND1', 'BCL2L2']",0.9999643490017845,0,0,2
274,PPAR-alpha pathway WP2878,0.6454632837228411,0.9381074168797954,0.4106911854466532,"['CCND1', 'APOA1']",0.9999643490017845,0,0,2
275,16p11.2 distal deletion syndrome WP4950,0.6480442551928031,0.9145854657113613,0.3967437818323332,"['C3', 'PLN', 'CD81']",0.9999643490017845,0,0,3
276,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.6480442551928031,0.9145854657113613,0.3967437818323332,"['CCND1', 'FGF1', 'GLI2']",0.9999643490017845,0,0,3
277,Vitamin A and carotenoid metabolism WP716,0.6534636396263996,0.9032258064516129,0.38429402688204267,"['CYP26A1', 'RBP4', 'RBP2', 'BCO1']",0.9999643490017845,0,0,4
278,Biomarkers for urea cycle disorders WP4583,0.654648862630504,1.016359918200409,0.4305872566790869,['GOT1'],0.9999643490017845,0,0,1
279,Glucuronidation WP698,0.654648862630504,1.016359918200409,0.4305872566790869,['PGM5'],0.9999643490017845,0,0,1
280,LDLRAD4 and what we know about it WP4904,0.654648862630504,1.016359918200409,0.4305872566790869,['TGFBR2'],0.9999643490017845,0,0,1
281,Serotonin Transporter Activity WP1455,0.654648862630504,1.016359918200409,0.4305872566790869,['IL1R1'],0.9999643490017845,0,0,1
282,Vitamin B12 Disorders WP4271,0.654648862630504,1.016359918200409,0.4305872566790869,['CUBN'],0.9999643490017845,0,0,1
283,Endochondral Ossification with Skeletal Dysplasias WP4808,0.6662686985971937,0.8920753584778287,0.3622381169378193,"['GHR', 'TGFB1', 'HMGCS1', 'TIMP3', 'FGFR3', 'GLI3']",0.9999643490017845,0,0,6
284,Endochondral Ossification WP474,0.6662686985971937,0.8920753584778287,0.3622381169378193,"['GHR', 'TGFB1', 'HMGCS1', 'TIMP3', 'FGFR3', 'GLI3']",0.9999643490017845,0,0,6
285,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.6772263116973817,0.8709606667641469,0.3394567246190755,"['MAPK11', 'BMP2', 'FGFR3']",0.9999643490017845,0,0,3
286,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.6772263116973817,0.8709606667641469,0.3394567246190755,"['RAB3B', 'RAB3A', 'RAB11A']",0.9999643490017845,0,0,3
287,Monoamine GPCRs WP58,0.6772263116973817,0.8709606667641469,0.3394567246190755,"['CHRM5', 'HTR2B', 'ADRA2C']",0.9999643490017845,0,0,3
288,IL-2 signaling pathway WP49,0.6787012823733991,0.8708945943968985,0.33753626335735565,"['RPS6', 'PTK2B', 'FOS', 'HRAS']",0.9999643490017845,0,0,4
289,Prostaglandin Synthesis and Regulation WP98,0.6787012823733991,0.8708945943968985,0.33753626335735565,"['HSD11B1', 'EDN1', 'HPGD', 'ANXA2']",0.9999643490017845,0,0,4
290,BMP Signaling Pathway in Eyelid Development WP3927,0.6810066692164192,0.8710266715381805,0.3346337961977337,"['NOTCH1', 'FGF10']",0.9999643490017845,0,0,2
291,Glycosaminoglycan degradation WP4815,0.6810066692164192,0.8710266715381805,0.3346337961977337,"['IDUA', 'SGSH']",0.9999643490017845,0,0,2
292,IL-3 signaling pathway WP286,0.6822313055844754,0.8708284543325527,0.33299306294525605,"['HCK', 'TGFB1', 'PTPN6', 'FOS', 'HRAS']",0.9999643490017845,0,0,5
293,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6913390544910557,0.8831870659431456,0.3260063403592982,"['PDGFRB', 'SHC4', 'SHC3', 'CCND1', 'EGF', 'RPS6', 'GAB1', 'BAX', 'HRAS', 'FGFR3']",0.9999643490017845,0,0,10
294,Alzheimer's disease WP2059,0.7016516128429496,0.8705632150190672,0.3084564576203764,"['ATP5MD', 'CASP7', 'CASP8', 'PPP3R2', 'PSEN2', 'CYCS', 'CALM3', 'FADD', 'GAPDH']",0.9999643490017845,0,0,9
295,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7016516128429496,0.8705632150190672,0.3084564576203764,"['MC4R', 'SLCO1C1', 'NHSL1', 'NOTCH1', 'TG', 'RPS6', 'DIO1', 'HRAS', 'TSHR']",0.9999643490017845,0,0,9
296,ATR Signaling WP3875,0.7033271820805518,0.8710926088226701,0.3065663109515393,['RAD9A'],0.9999643490017845,0,0,1
297,Canonical NF-KB pathway WP4562,0.7033271820805518,0.8710926088226701,0.3065663109515393,['NFKBIE'],0.9999643490017845,0,0,1
298,"Degradation pathway of sphingolipids, including diseases WP4153",0.7033271820805518,0.8710926088226701,0.3065663109515393,['NEU1'],0.9999643490017845,0,0,1
299,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.7033271820805518,0.8710926088226701,0.3065663109515393,['ELOB'],0.9999643490017845,0,0,1
300,Leptin and adiponectin WP3934,0.7033271820805518,0.8710926088226701,0.3065663109515393,['LEPR'],0.9999643490017845,0,0,1
301,Mitochondrial CII Assembly WP4920,0.7033271820805518,0.8710926088226701,0.3065663109515393,['SDHAF1'],0.9999643490017845,0,0,1
302,Nephrogenesis WP5052,0.7033271820805518,0.8710926088226701,0.3065663109515393,['MEIS1'],0.9999643490017845,0,0,1
303,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.7033271820805518,0.8710926088226701,0.3065663109515393,['TGFB1'],0.9999643490017845,0,0,1
304,Glycosylation and related congenital defects WP4521,0.7045754109505026,0.8313017586303154,0.29108855028877706,"['DPM3', 'MPI', 'DOLK']",0.9999643490017845,0,0,3
305,Sphingolipid pathway WP1422,0.7045754109505026,0.8313017586303154,0.29108855028877706,"['CERS4', 'SPHK1', 'SERINC1']",0.9999643490017845,0,0,3
306,Focal Adhesion WP306,0.7051533574919343,0.9007682458386683,0.31467435330090077,"['PDGFRB', 'SHC4', 'SHC3', 'CAV3', 'LAMB3', 'ITGB4', 'EGF', 'LAMB2', 'STYK1', 'FN1', 'VEGFB', 'TESK2', 'VEGFC', 'THBS4', 'ACTG1', 'MYL5', 'HCK', 'CCND1', 'COL5A3', 'FLNC', 'HRAS']",0.9999643490017845,0,0,21
307,Ebstein-Barr virus LMP1 signaling WP262,0.7135776407045543,0.8128900255754475,0.2743211450347568,"['HSP90AA1', 'TRADD']",0.9999643490017845,0,0,2
308,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.7135776407045543,0.8128900255754475,0.2743211450347568,"['EIF3I', 'EIF3CL']",0.9999643490017845,0,0,2
309,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7241137003193221,0.8236181878599912,0.2658695963563892,"['MAPK11', 'HSP90AA1', 'CCND1', 'BAX', 'FOS']",0.9999643490017845,0,0,5
310,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7249642170920312,0.8310423559014025,0.2672906303328347,"['IFI27L2', 'MAPK11', 'PRKCH', 'PRKCD', 'ETS1', 'HRAS']",0.9999643490017845,0,0,6
311,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7252330220574156,0.8126984126984127,0.2610893336658405,"['MAP1LC3A', 'MSTN', 'IGFBP5', 'PLD1']",0.9999643490017845,0,0,4
312,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7252330220574156,0.8126984126984127,0.2610893336658405,"['GAB1', 'PTK2B', 'FOS', 'HRAS']",0.9999643490017845,0,0,4
313,Hippo-Merlin Signaling Dysregulation WP4541,0.7257926720391816,0.8591983556012333,0.2753652376357649,"['PDGFRB', 'CCND1', 'PRKAR1A', 'CDH20', 'ITGB4', 'CDH22', 'FGFR4', 'FGFR3', 'HRAS', 'CDH18', 'CDH19']",0.9999643490017845,0,0,11
314,Endothelin Pathways WP2197,0.7301135135814069,0.7950914512037738,0.25010019725995797,"['ADCY10', 'EDN1', 'RIIAD1']",0.9999643490017845,0,0,3
315,Nanoparticle-mediated activation of receptor signaling WP2643,0.7301135135814069,0.7950914512037738,0.25010019725995797,"['MAPK11', 'FN1', 'HRAS']",0.9999643490017845,0,0,3
316,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.7357979316968204,0.8961523474524506,0.2749393137172333,"['CDKN1B', 'ITGB4', 'COL11A1', 'HIF3A', 'FGF1', 'THBS4', 'GYS2', 'GHR', 'GNG4', 'PELO', 'HRAS', 'PDGFRB', 'HSP90AA1', 'ANGPT2', 'ANGPT1', 'LAMB3', 'EGF', 'LAMB2', 'RPS6', 'FN1', 'VEGFB', 'VEGFC', 'PRLR', 'COL5A1', 'LPAR6', 'COL5A3', 'FGFR4', 'FGFR3', 'FGF10']",0.9999643490017845,0,0,29
317,Androgen receptor signaling pathway WP138,0.73595974339682,0.8461736004108885,0.25941978244422115,"['CCND1', 'KAT5', 'BAG1', 'RNF6', 'STUB1', 'CALR', 'FKBP4', 'ETV5', 'RAN', 'RAD9A']",0.9999643490017845,0,0,10
318,G1 to S cell cycle control WP45,0.7428329750270869,0.8125064069707842,0.241545201502089,"['CDKN1B', 'CCND1', 'CCNE2', 'GADD45A', 'RPA3', 'POLE2']",0.9999643490017845,0,0,6
319,Notch Signaling Pathway Netpath WP61,0.7428329750270869,0.8125064069707842,0.241545201502089,"['NOTCH1', 'MAML2', 'CCND1', 'HEY1', 'PSEN2', 'DLL3']",0.9999643490017845,0,0,6
320,Translation Factors WP107,0.7428329750270869,0.8125064069707842,0.241545201502089,"['EIF4A2', 'EEF1B2', 'EEF1G', 'EIF3I', 'EIF4H', 'EIF3CL']",0.9999643490017845,0,0,6
321,Purine metabolism and related disorders WP4224,0.7433078320699209,0.7620204603580563,0.22604956740085352,"['PRPS1', 'AOX1']",0.9999643490017845,0,0,2
322,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7433078320699209,0.7620204603580563,0.22604956740085352,"['PTGES2', 'HRAS']",0.9999643490017845,0,0,2
323,16p11.2 proximal deletion syndrome WP4949,0.745144212824513,0.8261516118652764,0.24303521999185826,"['CASP8', 'ASPHD1', 'KCTD13', 'GDPD3', 'ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT']",0.9999643490017845,0,0,8
324,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.745144212824513,0.8261516118652764,0.24303521999185826,"['TGFB1', 'CCND1', 'GADD45A', 'TCF7', 'CYCS', 'BAX', 'FOS', 'TGFBR2']",0.9999643490017845,0,0,8
325,15q11.2 copy number variation syndrome WP4940,0.7451471190102543,0.7621421267893661,0.2242020968964972,['TUBGCP4'],0.9999643490017845,0,0,1
326,Biotin Metabolism (including IEMs) WP5031,0.7451471190102543,0.7621421267893661,0.2242020968964972,['ACACB'],0.9999643490017845,0,0,1
327,Purine metabolism WP4792,0.7451471190102543,0.7621421267893661,0.2242020968964972,['PRPS1'],0.9999643490017845,0,0,1
328,Thiamine metabolic pathways WP4297,0.7451471190102543,0.7621421267893661,0.2242020968964972,['BCKDK'],0.9999643490017845,0,0,1
329,Corticotropin-releasing hormone signaling pathway WP2355,0.7473008805918954,0.8307821541907784,0.2419963650885767,"['CRHBP', 'NR4A1', 'HSP90AA1', 'TGFB1', 'STAR', 'PRKCD', 'IL18', 'CRH', 'FOS']",0.9999643490017845,0,0,9
330,Neovascularisation processes WP4331,0.7538807680277874,0.7618986693961105,0.21525241669428724,"['NOTCH1', 'TGFB1', 'ANGPT1']",0.9999643490017845,0,0,3
331,Gastrin signaling pathway WP4659,0.7555550094017961,0.8401382856129775,0.23549301975321624,"['EGR1', 'BMP2', 'PRKCH', 'CDKN1B', 'CCND1', 'KAT5', 'ANXA2', 'RPS6', 'PRKCD', 'PRKD1', 'FOS', 'HRAS']",0.9999643490017845,0,0,12
332,MAPK Signaling Pathway WP382,0.7662243205001993,0.8743015241294265,0.2328092769501914,"['FGF1', 'RASGRP3', 'RPS6KA5', 'PPP3R2', 'DUSP10', 'NTF3', 'FLNC', 'HRAS', 'DUSP4', 'PDGFRB', 'HSPA8', 'DUSP2', 'TGFB1', 'IL1R1', 'GADD45A', 'DUSP1', 'EGF', 'PRKCD', 'FOS', 'TGFBR2', 'NR4A1', 'MAPK11', 'DDIT3', 'FGFR4', 'FGFR3', 'FGF10']",0.9999643490017845,0,0,26
333,Glycogen Synthesis and Degradation WP500,0.7665478641459912,0.7617767537122376,0.20252454897089228,"['GYS2', 'PHKG1', 'CALM3', 'GYG1']",0.9999643490017845,0,0,4
334,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.7703507903847845,0.7171355498721228,0.1871073314160591,"['H3F3B', 'H2AFZ']",0.9999643490017845,0,0,2
335,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.7703507903847845,0.7171355498721228,0.1871073314160591,"['HTR2B', 'HRAS']",0.9999643490017845,0,0,2
336,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.7703507903847845,0.7171355498721228,0.1871073314160591,"['EGR1', 'RPS6KA5']",0.9999643490017845,0,0,2
337,Hepatitis B infection WP4666,0.772871580981552,0.835820895522388,0.21534288049636394,"['TICAM2', 'TGFB1', 'ATP6AP1', 'SLC10A1', 'FOS', 'TGFBR2', 'MAPK11', 'CASP8', 'CYCS', 'PTK2B', 'BAX', 'STAT6', 'FADD', 'HRAS']",0.9999643490017845,0,0,14
338,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7743632166326546,0.7989300944578557,0.20429780457859953,"['SFRP4', 'FRAT2', 'CCND1', 'WNT5B', 'TCF7', 'NOTUM', 'DKK1', 'CXXC4']",0.9999643490017845,0,0,8
339,Insulin Signaling WP481,0.7743702279395345,0.8495148542163906,0.2172253564277694,"['EGR1', 'XBP1', 'PRKCH', 'SHC3', 'RRAD', 'PRKCD', 'GAB1', 'FOS', 'GYS2', 'MAPK11', 'RPS6KA5', 'RHOJ', 'GYG1', 'HRAS', 'SGK2', 'PFKM', 'SH2B2', 'ARF6']",0.9999643490017845,0,0,18
340,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.7759316471349498,0.7313613101330604,0.18553966969495458,"['STAR', 'CALM3', 'CAMK1G']",0.9999643490017845,0,0,3
341,Cancer immunotherapy by CTLA4 blockade WP4582,0.781074538310528,0.6774028629856851,0.16737587919573088,['PTPN6'],0.9999643490017845,0,0,1
342,Dopamine metabolism WP2436,0.781074538310528,0.6774028629856851,0.16737587919573088,['TYR'],0.9999643490017845,0,0,1
343,Neuroinflammation WP4919,0.781074538310528,0.6774028629856851,0.16737587919573088,['FOS'],0.9999643490017845,0,0,1
344,Non-homologous end joining WP438,0.781074538310528,0.6774028629856851,0.16737587919573088,['DCLRE1C'],0.9999643490017845,0,0,1
345,TCA cycle in senescence WP5050,0.781074538310528,0.6774028629856851,0.16737587919573088,['GOT1'],0.9999643490017845,0,0,1
346,Transcriptional cascade regulating adipogenesis WP4211,0.781074538310528,0.6774028629856851,0.16737587919573088,['DDIT3'],0.9999643490017845,0,0,1
347,Copper homeostasis WP3286,0.7853036606237347,0.738630545082158,0.17851578086445244,"['CCND1', 'SCO2', 'COX17', 'ATOX1']",0.9999643490017845,0,0,4
348,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.7853036606237347,0.738630545082158,0.17851578086445244,"['ACTA2', 'ACTC1', 'ITGB4', 'ACTG1']",0.9999643490017845,0,0,4
349,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.7913667460111675,0.7615325474115838,0.17819387182726465,"['CDKN1B', 'TMSB4X', 'FN1', 'PFN4', 'NEFH', 'PFN2']",0.9999643490017845,0,0,6
350,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7948731951637575,0.6772378516624041,0.15547530859573913,"['H3F3B', 'SUV39H1']",0.9999643490017845,0,0,2
351,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7948731951637575,0.6772378516624041,0.15547530859573913,"['CASP8', 'BAX']",0.9999643490017845,0,0,2
352,Monoamine Transport WP727,0.7948731951637575,0.6772378516624041,0.15547530859573913,"['ADORA2A', 'IL1R1']",0.9999643490017845,0,0,2
353,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.7948731951637575,0.6772378516624041,0.15547530859573913,"['GOT1', 'SCO2']",0.9999643490017845,0,0,2
354,Trans-sulfuration and one-carbon metabolism WP2525,0.7948731951637575,0.6772378516624041,0.15547530859573913,"['AHCY', 'MAT2B']",0.9999643490017845,0,0,2
355,Zinc homeostasis WP3529,0.7948731951637575,0.6772378516624041,0.15547530859573913,"['SLC39A7', 'SLC39A3']",0.9999643490017845,0,0,2
356,Prion disease pathway WP3995,0.7963315725283345,0.7031729785056294,0.16014035498279386,"['HSPA5', 'RFX5', 'EBF1']",0.9999643490017845,0,0,3
357,TNF-alpha signaling pathway WP231,0.8003102899718738,0.7830448811968319,0.17442776079532146,"['CASP7', 'HSP90AA1', 'CASP8', 'TRADD', 'RFK', 'BAX', 'FADD', 'NFKBIE', 'HRAS']",0.9999643490017845,0,0,9
358,Melanoma WP4685,0.8027937437214067,0.7614102564102564,0.16724943925793812,"['CCND1', 'GADD45A', 'BAX', 'CALM3', 'FOS', 'ETS1', 'HRAS']",0.9999643490017845,0,0,7
359,Neural Crest Differentiation WP2064,0.8027937437214067,0.7614102564102564,0.16724943925793812,"['NOTCH1', 'ZIC1', 'WNT8A', 'ASCL1', 'ETS1', 'FGFR3', 'DLL3']",0.9999643490017845,0,0,7
360,IL-6 signaling pathway WP364,0.8028370756965717,0.7168458781362007,0.15742184956707622,"['HCK', 'PRKCD', 'GAB1', 'VIP']",0.9999643490017845,0,0,4
361,Integrated Cancer Pathway WP1971,0.8028370756965717,0.7168458781362007,0.15742184956707622,"['CDKN1B', 'CASP8', 'BAX', 'BACH1']",0.9999643490017845,0,0,4
362,3q29 copy number variation syndrome WP4906,0.8058895444919894,0.7459283046893797,0.16097773376636287,"['CASP7', 'TGFB1', 'NCBP2', 'DYNLT3', 'SLC51A', 'DYNLL2']",0.9999643490017845,0,0,6
363,PPAR signaling pathway WP3942,0.8109939238899254,0.7252634660421545,0.1519388645803419,"['FABP6', 'APOA1', 'ACSL5', 'ANGPTL4', 'PCK2']",0.9999643490017845,0,0,5
364,Wnt signaling WP428,0.8116094874075418,0.7806882383153569,0.16295772554602705,"['SFRP4', 'FRAT2', 'PPP3R2', 'CCND1', 'WNT5B', 'TCF7', 'GPC4', 'NOTUM', 'DKK1', 'CXXC4']",0.9999643490017845,0,0,10
365,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.8119393421927289,0.6096114519427402,0.1270001363615668,['BMP2'],0.9999643490017845,0,0,1
366,Leptin Insulin Overlap WP3935,0.8119393421927289,0.6096114519427402,0.1270001363615668,['LEPR'],0.9999643490017845,0,0,1
367,"NAD metabolism, sirtuins and aging WP3630",0.8119393421927289,0.6096114519427402,0.1270001363615668,['ROS1'],0.9999643490017845,0,0,1
368,BDNF-TrkB Signaling WP3676,0.8151540009652003,0.6770726714431935,0.1383789110239818,"['TRPC3', 'GAB1', 'HRAS']",0.9999643490017845,0,0,3
369,Fatty Acid Biosynthesis WP357,0.8170481153448359,0.6415399111589716,0.1296278178934608,"['ACSL5', 'ACACB']",0.9999643490017845,0,0,2
370,Glycerolipids and Glycerophospholipids WP4722,0.8170481153448359,0.6415399111589716,0.1296278178934608,"['PLD1', 'CDIPT']",0.9999643490017845,0,0,2
371,NRF2-ARE regulation WP4357,0.8170481153448359,0.6415399111589716,0.1296278178934608,"['AIMP2', 'SLC7A11']",0.9999643490017845,0,0,2
372,7q11.23 copy number variation syndrome WP4932,0.822472360744172,0.7707410947059091,0.1506339485129831,"['CLDN5', 'ATP5F1B', 'EIF4H', 'ATP5MC3', 'UBE2L6', 'GTF2IRD1', 'ACACB', 'GAPDH', 'ATP5F1E', 'ATP5MC1']",0.9999643490017845,0,0,10
373,Pathogenic Escherichia coli infection WP2272,0.8254496009017017,0.7083373046130385,0.13587826992823593,"['TUBB8', 'TUBA1C', 'TUBB6', 'ACTG1', 'TUBA8']",0.9999643490017845,0,0,5
374,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8254496009017017,0.7083373046130385,0.13587826992823593,"['BMP2', 'NOTCH1', 'TGFB1', 'MSTN', 'TCF7']",0.9999643490017845,0,0,5
375,ESC Pluripotency Pathways WP3931,0.8328525245083692,0.7610426296866974,0.13919370296848882,"['PDGFRB', 'WNT5B', 'EGF', 'GAB1', 'FOS', 'FGF1', 'FGFR4', 'FGFR3', 'HRAS', 'FGF10']",0.9999643490017845,0,0,10
376,Regulation of Microtubule Cytoskeleton WP2038,0.8344071743684084,0.6769073220686124,0.12254308925814905,"['SPRED1', 'PARD6A', 'CFL2', 'TESK2']",0.9999643490017845,0,0,4
377,1q21.1 copy number variation syndrome WP4905,0.83704990382042,0.6094117647058823,0.10839703834836469,"['FMO5', 'TJP2']",0.9999643490017845,0,0,2
378,Estrogen signaling pathway WP712,0.83704990382042,0.6094117647058823,0.10839703834836469,"['GPER1', 'FOS']",0.9999643490017845,0,0,2
379,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.83704990382042,0.6094117647058823,0.10839703834836469,"['CCND1', 'PRLR']",0.9999643490017845,0,0,2
380,MTHFR deficiency WP4288,0.83704990382042,0.6094117647058823,0.10839703834836469,"['CHDH', 'CYCS']",0.9999643490017845,0,0,2
381,SARS-CoV-2 mitochondrial interactions WP5038,0.83704990382042,0.6094117647058823,0.10839703834836469,"['NDUFB9', 'PHB']",0.9999643490017845,0,0,2
382,Sphingolipid Metabolism (general overview) WP4725,0.83704990382042,0.6094117647058823,0.10839703834836469,"['CERS4', 'SPHK1']",0.9999643490017845,0,0,2
383,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.83704990382042,0.6094117647058823,0.10839703834836469,"['CCND1', 'DKK1']",0.9999643490017845,0,0,2
384,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.8384546008067246,0.5541457519985127,0.09763762351087148,['RYR1'],0.9999643490017845,0,0,1
385,FOXA2 pathway WP5066,0.8384546008067246,0.5541457519985127,0.09763762351087148,['ABCC2'],0.9999643490017845,0,0,1
386,ID signaling pathway WP53,0.8384546008067246,0.5541457519985127,0.09763762351087148,['ID3'],0.9999643490017845,0,0,1
387,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.8384546008067246,0.5541457519985127,0.09763762351087148,['SFRP4'],0.9999643490017845,0,0,1
388,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.848385834868606,0.6302721208484806,0.1036291862560697,"['HCK', 'RPS6', 'STAT6']",0.9999643490017845,0,0,3
389,Kit receptor signaling pathway WP304,0.8516658697919177,0.6767418032786885,0.10865834113502452,"['RPS6', 'PTPN6', 'FOS', 'HRAS', 'SH2B2']",0.9999643490017845,0,0,5
390,Sphingolipid Metabolism (integrated pathway) WP4726,0.8550504022788985,0.5803434417245159,0.0908788010238256,"['CERS4', 'SPHK1']",0.9999643490017845,0,0,2
391,Airway smooth muscle cell contraction WP4962,0.8612329925373136,0.5079243353783232,0.07587892021384697,['RYR1'],0.9999643490017845,0,0,1
392,Target Of Rapamycin (TOR) Signaling WP1471,0.8629618533124556,0.6092118730808598,0.08978856476821724,"['IDI1', 'RRAGA', 'HMGCR']",0.9999643490017845,0,0,3
393,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8629618533124556,0.6092118730808598,0.08978856476821724,"['CASP7', 'CASP8', 'FADD']",0.9999643490017845,0,0,3
394,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8634955087006867,0.6619743406985032,0.0971557118075029,"['YAP1', 'DCLRE1C', 'KAT5', 'BAX', 'RAD9A']",0.9999643490017845,0,0,5
395,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8643696031907139,0.7668824481388848,0.11177681332749363,"['SHC4', 'EGR1', 'LINGO1', 'RAB3A', 'SHC3', 'RPS6', 'PRKCD', 'FOS', 'ACACB', 'BMP2', 'RPS6KA5', 'NTF3', 'PTK2B', 'HRAS', 'SH2B2']",0.9999643490017845,0,0,15
396,Glioblastoma signaling pathways WP2261,0.8668557945016184,0.7058246146295759,0.1008500864491162,"['PDGFRB', 'CDKN1B', 'PRKCH', 'CCND1', 'PRKCD', 'GAB1', 'SPRY2', 'HRAS']",0.9999643490017845,0,0,8
397,Leptin signaling pathway WP2034,0.8712141391952619,0.6873779983457403,0.0947670710179503,"['CCND1', 'CFL2', 'RPS6', 'LEPR', 'BAX', 'HRAS', 'ACACB']",0.9999643490017845,0,0,7
398,Ethanol effects on histone modifications WP3996,0.8712161891004433,0.5539176935596373,0.07636593206546104,"['AHCY', 'HAT1']",0.9999643490017845,0,0,2
399,Oxidative Stress WP408,0.8712161891004433,0.5539176935596373,0.07636593206546104,"['NOX3', 'FOS']",0.9999643490017845,0,0,2
400,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8737520663957564,0.6246799795186891,0.08430594826684079,"['ADCY10', 'TGFB1', 'BANF1', 'HRAS']",0.9999643490017845,0,0,4
401,ATM Signaling Pathway WP2516,0.8762904180124462,0.5895103509756662,0.07784939025904623,"['CRADD', 'GADD45A', 'RAD9A']",0.9999643490017845,0,0,3
402,IL-5 signaling pathway WP127,0.8762904180124462,0.5895103509756662,0.07784939025904623,"['SPRED1', 'RPS6', 'FOS']",0.9999643490017845,0,0,3
403,Vitamin D-sensitive calcium signaling in depression WP4698,0.8762904180124462,0.5895103509756662,0.07784939025904623,"['CALB1', 'GPX4', 'PVALB']",0.9999643490017845,0,0,3
404,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.8808009317380817,0.46881390593047034,0.05950356542739243,['SYTL4'],0.9999643490017845,0,0,1
405,Transcription co-factors SKI and SKIL protein partners WP4533,0.8808009317380817,0.46881390593047034,0.05950356542739243,['SATB2'],0.9999643490017845,0,0,1
406,B Cell Receptor Signaling Pathway WP23,0.8843946227751637,0.6858266066382905,0.08425510862270023,"['CD81', 'PRKCD', 'GAB1', 'PTPN6', 'ETS1', 'HRAS', 'CD22', 'RASGRP3']",0.9999643490017845,0,0,8
407,IL-4 signaling pathway WP395,0.8849396627901108,0.6090117767537122,0.07444305022852658,"['MAPK11', 'STAT6', 'PTPN6', 'FOS']",0.9999643490017845,0,0,4
408,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8849396627901108,0.6090117767537122,0.07444305022852658,"['CD4', 'IL5', 'PTPN6', 'FOS']",0.9999643490017845,0,0,4
409,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8849396627901108,0.6090117767537122,0.07444305022852658,"['EIF4A2', 'RPS6KA5', 'PRKCD', 'RPS6']",0.9999643490017845,0,0,4
410,Signal transduction through IL1R WP4496,0.8857066520365415,0.5297898365395307,0.06430031469719898,"['TGFB1', 'IL1R1']",0.9999643490017845,0,0,2
411,Netrin-UNC5B signaling pathway WP4747,0.8884550618243487,0.5710401740020471,0.06753761247591963,"['YAP1', 'ITGB4', 'PTK2B']",0.9999643490017845,0,0,3
412,Non-small cell lung cancer WP4255,0.8891403364376232,0.6657852564102564,0.07822989889884328,"['CASP8', 'CCND1', 'EGF', 'GADD45A', 'CYCS', 'BAX', 'HRAS']",0.9999643490017845,0,0,7
413,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8950442444505152,0.715681233933162,0.07935625732142577,"['CLDN5', 'MAPK11', 'CLDN20', 'NOTCH1', 'TGFB1', 'WNT5B', 'EIF5A2', 'FN1', 'WNT8A', 'HRAS', 'TGFBR2', 'DLL3']",0.9999643490017845,0,0,12
414,TGF-beta Signaling Pathway WP366,0.8950442444505152,0.715681233933162,0.07935625732142577,"['TGFBR3', 'YAP1', 'TGFB1', 'PARD6A', 'CCND1', 'CITED1', 'ITGB4', 'FN1', 'NEDD9', 'FOS', 'ETS1', 'TGFBR2']",0.9999643490017845,0,0,12
415,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8952524895045513,0.5941078765626366,0.06573773313960829,"['MAPK11', 'RPS6KA5', 'IL1R1', 'FOS']",0.9999643490017845,0,0,4
416,DNA damage response (only ATM dependent) WP710,0.8960181108952177,0.6845867556468173,0.07516396539334315,"['TGFB1', 'CDKN1B', 'CCND1', 'WNT5B', 'TCF7', 'BAX', 'HRAS', 'LDLR', 'PCK2']",0.9999643490017845,0,0,9
417,Male infertility WP4673,0.8960181108952177,0.6845867556468173,0.07516396539334315,"['ABCB1', 'MSH4', 'MSH5', 'HLA-DRA', 'PEX10', 'AHR', 'TEX15', 'ETV5', 'RAG1']",0.9999643490017845,0,0,9
418,Retinoblastoma gene in cancer WP2446,0.8972867556000337,0.6554871794871795,0.07104155962756092,"['CDKN1B', 'CCND1', 'CCNE2', 'H2AFZ', 'SUV39H1', 'RPA3', 'POLE2']",0.9999643490017845,0,0,7
419,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.8976107091215482,0.4352906806894537,0.04701958283189902,['MAPK11'],0.9999643490017845,0,0,1
420,MAPK pathway in congenital thyroid cancer WP4928,0.8976107091215482,0.4352906806894537,0.04701958283189902,['FOS'],0.9999643490017845,0,0,1
421,White fat cell differentiation WP4149,0.8986727075725807,0.5076726342710998,0.054237903203373856,"['DDIT3', 'EBF1']",0.9999643490017845,0,0,2
422,Hepatitis C and Hepatocellular Carcinoma WP3646,0.8995375026348248,0.5536894016934959,0.05862160722102138,"['CASP7', 'TGFB1', 'CCND1']",0.9999643490017845,0,0,3
423,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8995375026348248,0.5536894016934959,0.05862160722102138,"['PDE3A', 'CNGB3', 'CYCS']",0.9999643490017845,0,0,3
424,Notch Signaling WP268,0.8995375026348248,0.5536894016934959,0.05862160722102138,"['NOTCH1', 'PSEN2', 'DLL3']",0.9999643490017845,0,0,3
425,AGE/RAGE pathway WP2324,0.9031558968182231,0.608811475409836,0.06201359609625685,"['LGALS3', 'MSR1', 'CASP8', 'PRKCD', 'CYCS']",0.9999643490017845,0,0,5
426,Pancreatic adenocarcinoma pathway WP4263,0.9070723153084528,0.6578564197856143,0.06416277717815659,"['TGFB1', 'CCND1', 'EGF', 'GADD45A', 'PRKCD', 'BAX', 'PLD1', 'TGFBR2']",0.9999643490017845,0,0,8
427,DNA Repair Pathways Full Network WP4946,0.9073835343655603,0.7017994858611826,0.06820793264136177,"['POLE4', 'POLD4', 'BRIP1', 'FEN1', 'DCLRE1C', 'NEIL2', 'CENPX', 'POLD1', 'RPA3', 'POLE2', 'APEX1', 'POLE3']",0.9999643490017845,0,0,12
428,Integrated breast cancer pathway WP1984,0.9095156351672905,0.7153885743695316,0.06784966310388342,"['PLK3', 'GADD45A', 'TRADD', 'AHR', 'PHB', 'HMGCR', 'BACH1', 'RASGRP3', 'TGFBR2', 'CASP8', 'CCND1', 'BAX', 'FADD', 'FAU']",0.9999643490017845,0,0,14
429,IL17 signaling pathway WP2112,0.9102560235827851,0.4873248081841432,0.04582284686495958,"['TRAF3IP2', 'IL17RE']",0.9999643490017845,0,0,2
430,Intraflagellar transport proteins binding to dynein WP4532,0.9102560235827851,0.4873248081841432,0.04582284686495958,"['DYNLT3', 'DYNLL2']",0.9999643490017845,0,0,2
431,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.9102560235827851,0.4873248081841432,0.04582284686495958,"['YAP1', 'FYB1']",0.9999643490017845,0,0,2
432,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.9102560235827851,0.4873248081841432,0.04582284686495958,"['CDKN1B', 'HRAS']",0.9999643490017845,0,0,2
433,Globo Sphingolipid Metabolism WP1424,0.9120509243946447,0.40623721881390595,0.03739797587384476,['FUT2'],0.9999643490017845,0,0,1
434,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.9120509243946447,0.40623721881390595,0.03739797587384476,['NFKBIE'],0.9999643490017845,0,0,1
435,Transcription factor regulation in adipogenesis WP3599,0.9120509243946447,0.40623721881390595,0.03739797587384476,['PCK2'],0.9999643490017845,0,0,1
436,Urea cycle and metabolism of amino groups WP497,0.9120509243946447,0.40623721881390595,0.03739797587384476,['PYCR1'],0.9999643490017845,0,0,1
437,MECP2 and Associated Rett Syndrome WP3584,0.9182423978687777,0.6086109687339826,0.05191078682619091,"['GABRR2', 'SST', 'GAD1', 'RPS6', 'OPRK1', 'FKBP5']",0.9999643490017845,0,0,6
438,Interleukin-11 Signaling Pathway WP2332,0.9187694550651884,0.5219622751864308,0.044220671669016554,"['TGFB1', 'RPS6', 'HRAS']",0.9999643490017845,0,0,3
439,PDGF Pathway WP2526,0.9187694550651884,0.5219622751864308,0.044220671669016554,"['PDGFRB', 'FOS', 'HRAS']",0.9999643490017845,0,0,3
440,Neural Crest Cell Migration during Development WP4564,0.9205886291945762,0.4685421994884911,0.03876811829105095,"['FOS', 'EPHB3']",0.9999643490017845,0,0,2
441,The influence of laminopathies on Wnt signaling WP4844,0.9205886291945762,0.4685421994884911,0.03876811829105095,"['CCND1', 'TCF7']",0.9999643490017845,0,0,2
442,Rett syndrome causing genes WP4312,0.9214655604084455,0.5534608760415212,0.04526749640812482,"['SATB2', 'IMPDH2', 'TBL1X', 'GABRD']",0.9999643490017845,0,0,4
443,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.9244554513099928,0.3808154396728016,0.02991321124697211,['HRAS'],0.9999643490017845,0,0,1
444,Nicotine Activity on Dopaminergic Neurons WP1602,0.9244554513099928,0.3808154396728016,0.02991321124697211,['SLC18A2'],0.9999643490017845,0,0,1
445,AMP-activated protein kinase (AMPK) signaling WP1403,0.9259207219433342,0.5742054593257037,0.04419467719245548,"['GYS2', 'STRADB', 'LEPR', 'HMGCR', 'ACACB']",0.9999643490017845,0,0,5
446,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9259207219433342,0.5742054593257037,0.04419467719245548,"['SGCD', 'ITGB4', 'TCF7', 'SGCG', 'ACTG1']",0.9999643490017845,0,0,5
447,CAMKK2  Pathway WP4874,0.9297928172200557,0.451150895140665,0.03284085035572113,"['FIS1', 'MAP1LC3A']",0.9999643490017845,0,0,2
448,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9297928172200557,0.451150895140665,0.03284085035572113,"['PPP3R2', 'SUPT4H1']",0.9999643490017845,0,0,2
449,Melatonin metabolism and effects WP3298,0.9297928172200557,0.451150895140665,0.03284085035572113,"['PER2', 'EDN1']",0.9999643490017845,0,0,2
450,Pathways affected in adenoid cystic carcinoma WP3651,0.932376611619699,0.5635245901639344,0.03945712183294697,"['NOTCH1', 'MYCBP', 'FGFR4', 'HRAS', 'FOXP2']",0.9999643490017845,0,0,5
451,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.9351111411937766,0.35838445807770963,0.02404397357294031,['HPGD'],0.9999643490017845,0,0,1
452,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9351111411937766,0.35838445807770963,0.02404397357294031,['MAP1LC3A'],0.9999643490017845,0,0,1
453,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.9351111411937766,0.35838445807770963,0.02404397357294031,['IDH3B'],0.9999643490017845,0,0,1
454,Vitamin D in inflammatory diseases WP4482,0.9351111411937766,0.35838445807770963,0.02404397357294031,['DUSP1'],0.9999643490017845,0,0,1
455,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9355031436009247,0.5293083105144816,0.03528939418058373,"['MAPK11', 'CASP8', 'TRADD', 'FADD']",0.9999643490017845,0,0,4
456,p53 transcriptional gene network WP4963,0.9355031436009247,0.5293083105144816,0.03528939418058373,"['NOTCH1', 'GADD45A', 'BAX', 'SLC7A11']",0.9999643490017845,0,0,4
457,Regulation of toll-like receptor signaling pathway WP1449,0.9364636342196639,0.6159601483396224,0.04043445104793003,"['MAPK11', 'TICAM2', 'CASP8', 'PELI3', 'PELI2', 'PTPN6', 'FADD', 'FOS']",0.9999643490017845,0,0,8
458,Amino Acid metabolism WP3925,0.9366969723177057,0.579483048985868,0.03789555536905474,"['LDHA', 'PKM', 'GOT1', 'PYCR1', 'ACSS1', 'HIBCH']",0.9999643490017845,0,0,6
459,Mesodermal commitment pathway WP2857,0.9384304925605279,0.6400670397102154,0.04067401243723321,"['YAP1', 'MEIS1', 'CCND1', 'PRKAR1A', 'TRIM5', 'SLC2A12', 'PBX3', 'RPL38', 'TOX', 'DKK1']",0.9999643490017845,0,0,10
460,ATM Signaling Network in Development and Disease  WP3878,0.9413734759248815,0.48063351828906964,0.02903763047779131,"['DCLRE1C', 'KAT5', 'HMGN1']",0.9999643490017845,0,0,3
461,Histone Modifications WP2369,0.9413734759248815,0.48063351828906964,0.02903763047779131,"['SET', 'H3F3B', 'SUV39H1']",0.9999643490017845,0,0,3
462,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.9442644426825896,0.33844580777096117,0.01940953611131563,['RPS6'],0.9999643490017845,0,0,1
463,Immune response to tuberculosis WP4197,0.9442644426825896,0.33844580777096117,0.01940953611131563,['IFIT3'],0.9999643490017845,0,0,1
464,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.9442644426825896,0.33844580777096117,0.01940953611131563,['SPHK1'],0.9999643490017845,0,0,1
465,NAD+ biosynthetic pathways WP3645,0.9442644426825896,0.33844580777096117,0.01940953611131563,['ACMSD'],0.9999643490017845,0,0,1
466,Triacylglyceride synthesis WP325,0.9442644426825896,0.33844580777096117,0.01940953611131563,['AGPAT1'],0.9999643490017845,0,0,1
467,Neural Crest Cell Migration in Cancer WP4565,0.9452573206999577,0.419966487344563,0.023643311738812116,"['FOS', 'EPHB3']",0.9999643490017845,0,0,2
468,Wnt signaling pathway and pluripotency WP399,0.9459124004677267,0.5832595714787495,0.03243233170091458,"['PRKCH', 'CCND1', 'WNT5B', 'PRKCD', 'TCF7', 'PRKD1', 'LDLR']",0.9999643490017845,0,0,7
469,Cell cycle WP179,0.946054053208612,0.61489167801029,0.03409917025354558,"['TGFB1', 'CDKN1B', 'CCND1', 'PTTG1', 'CCNE2', 'GADD45A', 'CDC14A', 'ANAPC11', 'SMC1B']",0.9999643490017845,0,0,9
470,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9475070750007779,0.46827021494370524,0.025249539742190824,"['MAP1LC3A', 'CP', 'FTL']",0.9999643490017845,0,0,3
471,Toll-like Receptor Signaling Pathway WP75,0.9488290584202128,0.5337305867126834,0.028035066224935425,"['MAPK11', 'TICAM2', 'CASP8', 'FADD', 'FOS']",0.9999643490017845,0,0,5
472,Regulation of Actin Cytoskeleton WP51,0.9489227281536915,0.6454125622767705,0.03383763055516685,"['PDGFRB', 'EGF', 'CFL2', 'TMSB4X', 'CHRM5', 'FN1', 'FGF1', 'FGFR4', 'FGFR3', 'WASF2', 'ACTG1', 'FGF10']",0.9999643490017845,0,0,12
473,Fatty acid beta-oxidation WP143,0.9517153829662535,0.40593350383631716,0.020089347237637122,"['TPI1', 'ACSL5']",0.9999643490017845,0,0,2
474,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.9521270896054805,0.3206059627596599,0.015727888364139294,['PTPN6'],0.9999643490017845,0,0,1
475,G Protein Signaling Pathways WP35,0.9542887714207848,0.5676102564102564,0.026557892406246925,"['PRKCH', 'PRKD3', 'PRKAR1A', 'GNG4', 'PRKCD', 'PRKD1', 'HRAS']",0.9999643490017845,0,0,7
476,DNA IR-damage and cellular response via ATR WP4016,0.9555093413402699,0.5447034433164776,0.024789856219384194,"['SEM1', 'FEN1', 'BRIP1', 'POLN', 'ABRAXAS1', 'RAD9A']",0.9999643490017845,0,0,6
477,Amyotrophic lateral sclerosis (ALS) WP2447,0.9574413810388237,0.3928058741027968,0.01708343410808242,"['BAX', 'NEFH']",0.9999643490017845,0,0,2
478,Type 2 papillary renal cell carcinoma WP4241,0.9574413810388237,0.3928058741027968,0.01708343410808242,"['TGFB1', 'ELOB']",0.9999643490017845,0,0,2
479,PKC-gamma calcium signaling pathway in ataxia WP4760,0.9588809890830152,0.30455010224948875,0.012787544339679153,['TRPC3'],0.9999643490017845,0,0,1
480,Toll-like Receptor Signaling related to MyD88 WP3858,0.9588809890830152,0.30455010224948875,0.012787544339679153,['TICAM2'],0.9999643490017845,0,0,1
481,Fluoropyrimidine Activity WP1601,0.9646824213074002,0.29002337131171485,0.010428175727066072,['DPYD'],0.9999643490017845,0,0,1
482,Nanoparticle triggered autophagic cell death WP2509,0.9646824213074002,0.29002337131171485,0.010428175727066072,['MAP1LC3A'],0.9999643490017845,0,0,1
483,Signal Transduction of S1P Receptor WP26,0.9646824213074002,0.29002337131171485,0.010428175727066072,['SPHK1'],0.9999643490017845,0,0,1
484,MET in type 1 papillary renal cell carcinoma WP4205,0.9650153204797361,0.4679979518689196,0.016666016223592182,"['RPL11', 'GAB1', 'ETS1', 'HRAS']",0.9999643490017845,0,0,4
485,Ras signaling WP4223,0.9653688885533646,0.6345011944907475,0.02236298365974039,"['PDGFRB', 'SHC4', 'SHC3', 'GAB1', 'RASAL1', 'PLD1', 'ETS1', 'RASGRP3', 'GNG4', 'CALM3', 'FGFR4', 'FGFR3', 'HRAS', 'ARF6']",0.9999643490017845,0,0,14
486,ErbB signaling pathway WP673,0.9676323841402511,0.5386887374229147,0.017724492919538374,"['SHC4', 'CDKN1B', 'SHC3', 'CCND1', 'EGF', 'GAB1', 'HRAS']",0.9999643490017845,0,0,7
487,Prolactin Signaling Pathway WP2037,0.968360811675251,0.49048122686409307,0.01576922738741412,"['RPS6', 'PTPN6', 'FOS', 'HRAS', 'PRLR']",0.9999643490017845,0,0,5
488,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9696656481177686,0.27681725227737497,0.008527067446592911,['TICAM2'],0.9999643490017845,0,0,1
489,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9716475489885582,0.45058883768561186,0.01295990112425836,"['GHR', 'PDGFRB', 'MAPK11', 'DUSP2']",0.9999643490017845,0,0,4
490,Circadian rhythm related genes WP3594,0.9718391805710677,0.6204492263074258,0.017723095107277542,"['EGR1', 'MAGEL2', 'AHCY', 'KCNH7', 'SUV39H1', 'BHLHE41', 'AHR', 'HCRTR2', 'PER2', 'STAR', 'ADORA2A', 'CRH', 'ID3', 'RPS27A']",0.9999643490017845,0,0,14
491,Interferon type I signaling pathways WP585,0.9733990522855126,0.40562947799385873,0.010936239308199654,"['RPS6KA5', 'RPS6', 'PTPN6']",0.9999643490017845,0,0,3
492,Gastric Cancer Network 2 WP2363,0.9739460137972744,0.2647594914199342,0.006989492826766238,['BRIX1'],0.9999643490017845,0,0,1
493,Cardiac Hypertrophic Response WP2795,0.9763079077866986,0.3967780695118152,0.009513652138220955,"['TGFB1', 'EGF', 'PRKD1']",0.9999643490017845,0,0,3
494,Wnt signaling in kidney disease WP4150,0.9776226095429312,0.25370654396728015,0.005741775691925894,['WNT5B'],0.9999643490017845,0,0,1
495,Glycerophospholipid Biosynthetic Pathway WP2533,0.9807805625166885,0.24353783231083845,0.004726224732362005,['CDIPT'],0.9999643490017845,0,0,1
496,Lipid Metabolism Pathway WP3965,0.9807805625166885,0.24353783231083845,0.004726224732362005,['PRKAR1A'],0.9999643490017845,0,0,1
497,IL-1 signaling pathway WP195,0.9812424778356964,0.38018167860798363,0.007198997016858386,"['IL1R1', 'PELI2', 'HSPB2']",0.9999643490017845,0,0,3
498,Splicing factor NOVA regulated synaptic proteins WP4148,0.9827068301736465,0.3202584466280792,0.005586730288591671,"['NTNG1', 'EPB41']",0.9999643490017845,0,0,2
499,Thermogenesis WP4321,0.9827554588414581,0.49454979129397736,0.008602673855500866,"['ADCY10', 'MAPK11', 'RPS6', 'DPF3', 'ACSL5', 'HRAS', 'ACTG1']",0.9999643490017845,0,0,7
500,Ciliopathies WP4803,0.9829206194294976,0.5899382398353062,0.01016281619230325,"['DNAH11', 'AK7', 'CCDC28B', 'GLI3', 'GLI2', 'PKHD1', 'TMEM17', 'EVC', 'MAK', 'HYDIN', 'CCDC65', 'CCNQ', 'CCDC151', 'DNAI1']",0.9999643490017845,0,0,14
501,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9858227537113842,0.2254601226993865,0.0032192782451272027,['FOS'],0.9999643490017845,0,0,1
502,Nuclear receptors WP170,0.9878237832237765,0.21738971662284545,0.0026632314624923,['NR4A1'],0.9999643490017845,0,0,1
503,RANKL/RANK signaling pathway WP2018,0.9897774381621439,0.2896602119108513,0.002976308227897172,"['FOS', 'PAPSS2']",0.9999643490017845,0,0,2
504,MAPK Cascade WP422,0.9910185859987513,0.20286298568507158,0.0018302278355522895,['HRAS'],0.9999643490017845,0,0,1
505,Energy Metabolism WP1541,0.9910458971176291,0.28290013679890563,0.0025445259814117814,"['PPP3R2', 'UCP3']",0.9999643490017845,0,0,2
506,Chemokine signaling pathway WP3929,0.991124773218751,0.47614161108260644,0.004244729232962212,"['SHC4', 'HCK', 'SHC3', 'GNG4', 'PRKCD', 'PTK2B', 'DOCK2', 'HRAS']",0.9999643490017845,0,0,8
507,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.992286394865342,0.19630252655188338,0.001520070354190975,['GABRD'],0.9999643490017845,0,0,1
508,EGF/EGFR signaling pathway WP437,0.9923101012036534,0.527372303565441,0.004071113005380053,"['NDUFA13', 'RPS6KA5', 'EGF', 'PRKCD', 'GAB1', 'PTK2B', 'SPRY2', 'FOS', 'PLD1', 'HRAS', 'AP2M1', 'ARF6']",0.9999643490017845,0,0,12
509,Phosphoinositides metabolism WP4971,0.993375266239389,0.19015209611451941,0.0012638981429068273,['PIP4P1'],0.9999643490017845,0,0,1
510,mRNA Processing WP411,0.9949508905334158,0.46663244353182753,0.0023620464343374775,"['SF3B5', 'LSM7', 'SF3A1', 'NCBP2', 'CSTF2T', 'SNRPE', 'SNU13', 'SRSF9', 'LSM2']",0.9999643490017845,0,0,9
511,Ciliary landscape WP4352,0.9951240123637228,0.5565143494009474,0.002720194306616535,"['YAP1', 'DOCK5', 'EXOC8', 'NDUFA5', 'DYNLT3', 'HTRA2', 'COPS7A', 'MYL6B', 'COX6C', 'DYNLL2', 'LSM4', 'PSMD8', 'EXOSC4', 'CDH23', 'TMED1', 'VIM', 'COPS8']",0.9999643490017845,0,0,17
512,G13 Signaling Pathway WP524,0.9958033937169267,0.1738095238095238,0.0007309449587906621,['CFL2'],0.9999643490017845,0,0,1
513,Common Pathways Underlying Drug Addiction WP2636,0.9973414640821682,0.16004735765794856,0.0004260582457382317,['ACTG1'],0.9999643490017845,0,0,1
514,Joubert Syndrome WP4656,0.9981582574268317,0.2719335767426939,0.0005012934139021905,"['TMEM17', 'KAT5', 'PDE6B']",0.9999643490017845,0,0,3
515,Integrin-mediated Cell Adhesion WP185,0.9983174050631949,0.30734929060776345,0.0005175799210985766,"['SHC3', 'CAV3', 'ITGB4', 'HRAS']",0.9999643490017845,0,0,4
516,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9983765914216355,0.2679119754350051,0.000435284016746488,"['EDN1', 'TGFB1', 'EGF']",0.9999643490017845,0,0,3
517,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9990830252263665,0.1350715746421268,0.00012391404829664759,['HRAS'],0.9999643490017845,0,0,1
518,Wnt Signaling Pathway WP363,0.9992122384416045,0.1321241219880857,0.00010412332180085952,['CCND1'],0.9999643490017845,0,0,1
519,Ectoderm Differentiation WP2858,0.9998197378060115,0.27788483230560984,5.0096644948762144e-05,"['MAFB', 'SPRY2', 'TBL1X', 'PTPN13', 'GLI3']",0.9999643490017845,0,0,5
520,Fragile X Syndrome  WP4549,0.9998396244025637,0.27533532041728764,4.416060774382593e-05,"['PRKAR1A', 'GAD1', 'GAB1', 'GABRD', 'AP2M1']",0.9999643490017845,0,0,5
521,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.999857307079155,0.2728317456801063,3.8933936554967885e-05,"['SLCO1C1', 'MAPK11', 'RPS6KA5', 'SHC3', 'HRAS']",0.9999643490017845,0,0,5
522,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999643490017845,0.18542811187934743,6.610815127484781e-06,"['TMEM17', 'EVC', 'TULP3']",0.9999643490017845,0,0,3
